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Abstract
In stereotactic laser neurosurgery a tumor in the human brain is resected by
a pulsed high energy laser beam. The laser beams for diagnosis and ablation of
cancerous tissue are supplied through a probe. The whole resection is planned
with a computer system. These planning data are based on previously obtained
CT and MRT imaging. During the operation the complete process (diagnosis and
resection) is guided and controlled by a computer system. One important part
of the surgical system is the OligoChannel Spectrum Analyzer (OCSA), of which
the principles and development are described in this work. The OCSA analyzes
the autofluorescence spectrum of each observed tissue point in order to determine
its kind. This is possible since autofluorescence spectra of healthy and cancerous
tissue show characteristic differences. In contrast to commonly used techniques,
the OCSA uses only a few detectors. By evaluation of the data obtained with the
OCSA, an immediate decision can be made whether a specific tissue point should
be ablated or not. To demonstrate the new technique, some results obtained
with different tissue samples (human kidney and various mouse tissues) will be
presented.
Zusammenfassung
In der stereotaktischen Laser-Neurochirurgie soll ein tief sitzender inopera-
bler Gehirntumor u¨ber plasmainduzierte Laser-Ablation entfernt werden. Hierfu¨r
werden die Laserstrahlen fu¨r Diagnose und Ablation u¨ber eine Lasersonde zum
Tumor gefu¨hrt. Die gesamte Operation wird auf CT- und MRT-Daten basierend
geplant und durch einen Rechner u¨berwacht. Eine wichtige Komponente des
Operationssystems ist der OligoChannel Spektral Analysator (OCSA), dessen
Entwicklung und Funktionsweise in der vorliegenden Arbeit vorgestellt werden.
Der OCSA teilt Autofluoreszenzspektren untersuchter Gewebepunkte auf einige
wenige Kana¨le auf, um Aussagen u¨ber die Art des untersuchten Gewebes machen
zu ko¨nnen. Dies ist mo¨glich, weil die Autofluoreszenzspektren, die durch die
Bestrahlung von Gewebe mit Laserlicht entstehen, sich in Abha¨ngigkeit von
der Gewebeart charakteristisch unterscheiden. Mit Hilfe der Informationen aus
den Autofluoreszenzspektren wird entschieden, wie mit einem analysierten Punkt
im Gewebe weiter verfahren werden soll (Ablation, Koagulation oder Verbleib).
Zur Demonstration der Funktionsweise dieser neuen Technik werden in der vor-
liegenden Arbeit auch einige Ergebnisse, die mit Mausgewebe und menschlichem
Gewebe erzielt wurden, vorgestellt.
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In stereotactic laser neurosurgery tumors in human brains are resected through
an optical probe by laser ablation (Fig.1.1) [1, 2]. The probe is guided through
the human brain on a predefined pathway. The optimal access to the tumor is
determined by matching MRI (Magnetic Resonance Imaging) and CT (Computer
Tomography) data obtained prior to the operation [3]. During the ongoing opera-
tion, the aim is to find a route to the tumor while causing relatively little damage
to vital areas of the brain. The complete operation is done under MRI control.
Therefore, the progress of the operation can be evaluated at any time and, if
necessary, the strategy for the ongoing operation can be changed, dependent on
the current conditions.
Figure 1.1: The probe tip with laser beam exiting perpendicular to the probe
axis.
One serious problem in brain surgery is damage to blood vessels. Due to the
minimal invasive access, there is no way of quick intervention if bleeding occurs.
Therefore, blood vessels have to be detected with high reliability and closed by
coagulation. This coagulation is done by a continuous wave (cw) laser delivering
30 W in the infrared (IR). Besides the MR-monitoring, an integrated confocal
microscope is used in order to control the ongoing surgery [4, 5, 6, 7, 8, 9].
During the operation blood vessels, cancerous tissue, and healthy parts of the
brain have to be identified. Thus, real time information about the composition
of the tissue in each observed sample volume is of major interest. Since the used
laser system is working at a pulse repetition rate of about 4 kHz (every single
pulse can be switched), the detection system needs to work with at least this
frequency. The higher the achieved spatial precision and reliability of detection,
the smaller the ablated security regions of healthy tissue can be chosen.
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The diagnosis of tissue on biochemical, structural, or physiological levels
can be done by measurements with light, like light microscopy, fluorescence mi-
croscopy or fluorescence spectroscopy. The spectrum remitted by the tissue sam-
ple is influenced by changes in biochemistry and scattering. It is very unlikely that
the biochemistry of biological tissue does not change with pathological changes,
because every change, like the altered proliferation of tumorous cells is always
accompanied by changes in the biochemistry of the cell due to e.g. changed sup-
ply conditions. As tissue scattering is usually unspecific to pathological changes,
the changes of biochemistry are decoupled from the scattering in a spectroscopic
approach.
There are different methods for receiving information about the observed type
of tissue by fluorescence. One possibility is the use of fluorescent dyes like 5-
ALA (5-aminolevulinic acid) [10, 11, 12], which induces a significantly higher
accumulation of PpIX (protoporphyrin IX) in cancerous tissue than in healthy
tissue, or ClAlPcS4 (chloro-aluminium phthalocyanine tetrasulfonate) [13], which
provide good results in detecting cancerous tissue. The high fluorescence intensity
obtained by the use of fluorescent dyes helps finding the exact location of a tumor.
Usually, it is then sufficient to measure the complete intensity of the fluorescence
signal. The latter is done by only blocking the stimulating wavelength in the
spectrum. This method has the advantage of simplicity and high speed. No
spectroscopic techniques have to be used. However, the use of fluorescent dyes
has some disadvantages. First, applying exogenous material may cause serious
side effects, and second, their application is difficult since it is necessary to follow
a strict time-table of administration.
The disadvantages of exogenous dyes can be avoided by making use of the
autofluorescence properties of tissues. Unfortunately, detection of the overall
autofluorescence intensity does not provide sufficient information for reliable iden-
tification of different types of tissue. Nonetheless, the shapes of autofluorescence
spectra of different tissues contain information which is sufficient for detection
of their status (cancer, healthy tissue) [14, 15, 16, 17]. Various tissues have
been examined by autofluorescence spectroscopy [18, 19, 20, 21], e.g. skin tissue
[22, 23, 24]. It was shown that comparison of the shapes of autofluorescence
spectra allows tissue discrimination with high reliability.
A great variety of setups and light sources is used for autofluorescence spec-
troscopy [25, 26]. In order to access the spectral information, each spectrum has
to be analyzed with an Optical Multichannel spectrum Analyzer (OMA). The
spectra obtained with OMAs show high spectral resolution but poor sensitivity
and speed when CCD devices are used as detectors. Although high signals or
long exposure times are required for obtaining spectra, results in literature and
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Figure 1.2: Autofluorescence spectra of cancerous and healthy human lung tissue
[27]. The excitation wavelength is 488 nm.
our own experiments with a video-based spectrograph show that this procedure
is suitable for detection of cancerous tissue [27, 28]. Fig.1.2 shows spectra of
healthy and cancerous human lung tissue. There is a clear and characteristic dif-
ference between the shapes of the two spectra, which can be used to differentiate
between cancerous and healthy tissue. However, it should be mentioned that a
working combination of stimulating wavelength and analytic procedure has to be
found for each specific application. Excitation with a certain wavelength does
not inevitably lead to a characteristic spectral shape.
As long exposure times and high intensities are not available in stereotactic
laser neurosurgery, a refined technique had to be found. This is called OligoChan-
nel Spectral Analyzer (OCSA).
In the OCSA, the emitted autofluorescence spectrum of the observed tissue is
divided into a few (oligo) spectral bands. The fluorescence intensity is integrated
within these bands. By concentrating the whole spectrum on just three detec-
tors, higher signals can be obtained. On the other hand, compared to a simple
fluorescence microscope setup with just one detector, information is gained by
observing several channels. As shown in the experiments presented later in this
work, this information is sufficient for a distinction of different types of tissue.
This work describes the development of the OCSA. The principles and methods
used for the setup are described. At the end, results obtained with the system,
are presented.
A second aspect for the improvement of stereotactic neurosurgery is to eval-
uate the use of adaptive optics (AO). Adaptive optics is a technique for en-
hancement of the beam quality in optical systems. It is used for correction of
aberrations imprinted on the beams for ablation, coagulation and diagnosis by
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optical distortions. Such distortions are mainly induced by the biological tissue
and irrigation liquid inside the operational cavity that has to be passed by the
laser beams. Besides this, some improvement in the optical quality of the optical
setup itself can be achieved by adaptive optics.
Adaptive optics is known from its application in astronomy, where it is used
to correct aberrations of the signal induced by atmospheric distortions. These
distortions are mainly due to turbulences in the atmosphere, which can be de-
scribed by the model introduced by Kolmogorov in 1961. As the use of adaptive
optics is currently just experimental and quite far from an application in the
actual stereotactic setup, the principles are described in Appendix A.
In stereotactic neurosurgery, the AO is intended to correct the laser beams
for diagnosis, ablations, and coagulation. For diagnosis the use of AO would be
helpful in order to collect as much signal as possible from the observed point,
because the light levels of the autofluorescence of the human brain tissue are
very low. The high energy laser beams, especially those used for ablation, are
corrected in order to ensure a good beam quality. This results in a sufficiently
small focal point and ensures high intensities for the generation of plasma induced
ablation.
Chapter 2
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Neurosurgical resection and radiotherapy are the standard methods for treat-
ment of tumors in the human brain [29]. Tumors demand additional space in the
brain (Fig.2.1), causing increased intracranial pressure. Even with the improve-
ment of the lately developed microsurgical methods, healthy brain tissue is often
traumatized during operations. This leads to heavy and often irreversible side
effects, like palsy, impaired vision, hearing, and speech or mental disorders. It is
difficult or impossible to resect tumors deep in the human brain, because they
cannot be accessed without damaging vital areas of the brain.
In radiotherapy, heavy doses of X-ray radiation are applied to the tumor.
Usually vital areas of the brain are also affected by the ionizing radiation. Besides
this, the necrotic tissue remaining in the head, causes side effects due to its toxic
properties.
Figure 2.1: A tumor (T) is a space demanding process and causes mass displace-
ments in the brain [30].
These problems are solved by a new approach, the so-called ’laser ablation’.
Short laser pulses with time duration of about 30 ps lead to plasma-induced
ablation of tissue, whereas the surrounding tissue is not affected. The tissue can
be ablated gently and very precisely in the 50 µm-range.
Just by using a combination of modern laser technology with the stereotactic
approach, i.e. localization, therapy planning and operation procedures, the laser
ablation method can play off its advantages (with stereotactic methods a brain
area is accessed and treated point by point). On the basis of three-dimensional
graphical data, which can be gained with the help of MRI and CT, the position
of the tumor within the brain can be determined prior to the operation.
In order to utilize the advantages, namely high accuracy of the ablation pro-
cess, of this method, a detection system, which analyzes every point in the brain
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before any action (ablation, coagulation, none) takes place, is included. It is
particularly difficult to determine the crossover region from tumorous to healthy
brain tissue with the required precision only from the MRI and CT data. Every
point has to be closely examined in order to make sure that every cancer cell and
a minimum of healthy cells are ablated.
Another serious problem are blood vessels. They have to be determined with
high reliability in order not to be injured since this would cause bleedings. Thus,
to access low-lying tumors with the laser beam, a guiding system is used. A
central part of this system is a scanning probe tip (see chapter 2.2), which can be
integrated into an existing stereotactic surgical system. The positioning of the
probe in the area of the tumor is done by a stereotactic system. Its coordinates are
defined during the initial 3D imaging of localizers prior to the operation (Fig.2.2).
The progress of the operation is monitored with a MRI system integrated in the
surgical system.
In the first step, the system is used to ablate necrotic tissue killed by ra-
diotherapy. The ablated tissue is removed from the surgical cavity by an iriga-
tion/suction unit integrated in the probe. Later on, the method will be applied
without prior radiotherapy. Only a low dose irradiation after surgery is planned
to kill diffuse infiltrations of tumorous tissue in healthy brain areas.
2.1 Stereotactic Treatment
A stereotactic base ring is invasively fixed to the patient’s head (Fig.2.2). This
base ring defines an immovable coordinate system relative to the patient’s head,
the so-called stereotactic coordinate system. Measurement and treatment devices
are attached to this ring, so that all coordinates can be uniquely defined relative
to the ring. Thereby, tumor areas, organs at risk (OARs) [31], and the optimal
access to the tumor can be defined. Thus, an optimal predefined path to the
tumor can be chosen with very high accuracy, whereas damages of vital areas can
be minimized. The accuracy of this method is in the range of a few tenths of a
millimeter.
2.1.1 Stereotactic Radiation Therapy
State of the art in the treatment of non-operable tumors is stereotactic radio-
therapy [3]. Planning of the irradiation process is based on CT an MRI data,
and the location of the target structures and organs at risk is determined. The
X-ray radiation is usually generated by a linear accelerator (Fig.2.3).
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Figure 2.2: left: Patient with stereotactic ring in combination with localizers
attached to the head. right: Schematic drawing of a stereotactic system after
Riechert/Mundinger. The stereotactic bow mounted to the stereotactic ring fixes
the position of the instrument.
2.1.2 Intensity Modulated Radiation Therapy
Figure 2.3: Treatment setup during IMRT. Multi leaf collimator attached to the
gantry of a linac.
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Figure 2.4: Open multi-leaf collimator with detailed view of the lamellas forming
the beam.
An enhancement of stereotactic radiation therapy is the Intensity Modulated
Radiation Therapy (IMRT). The irradiation field is spatially modulated by a
multi-leaf collimator (Fig.2.4). The optimal dose distribution can be ascertained
very precisely, ensuring that the dose in the tumor is sufficiently high while the
dose in organs at risk is lower than a critical threshold dose. The three dimen-
sional dose gradients can be higher than in conventional radiation therapy. This
enables the treatment of tumors lying nearby OARs, like blood vessels or nerves.
2.2 Stereotactic Laser Neurosurgery
As an alternative to the above mentioned methods brain tumors can be treated
with laser radiation. On this occasion only thermal processes, which have been
used in medicine during the last 30 years, are used for treatment. High energy
doses are applied to the tissue, causing denaturation (Nd:YAG-laser) or vapor-
ization (CO2-laser) of the irradiated tissue. The tissue is not removed by this
method, therefore the brain is traumatized due to the high volume of the remain-
ing necrotic tissue. However, laser treatment opens up the possibility of very
precise ablation [33].
In Fig.2.5 an overview of the surgical system is given. The high energy laser
beams for tissue ablation (5) and coagulation (6) are delivered to the probe (2)
by a mirror arm (4). The laser beams are guided to the point of interest in the
brain by an optical system, which is assembled inside the probe. The probe itself
consists of two tubes which can be moved and rotated. In the inner tube a lens is
located which focuses the parallel beam. At the end of the outer tube a deflecting
mirror is attached at an angle of 45◦. With this setup, by varying the position
of lens and mirror, the beam can be focused within a cylindrical volume with
diameter and height of about 5 cm each (Fig.2.6) [34].
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Figure 2.5: Overview of the setup of stereotactic laser neurosurgery. A stereotac-
tic base ring (1) is attached to the patient’s head, the laser probe (2) is mounted
to the ring and a laser scanning microscope (3) is integrated into the probe for
diagnostic purposes. The two high energy lasers (5, 6) for ablation and coagu-
lation are delivered through a mirror arm (4). The surgery is planned based on
CT- and MRI-data (7) obtained prior to the operation and the whole system is
computer-controlled.
Cancerous tissue is ablated by a picosecond (ps) laser. Its short high energy
pulses resect tissue through plasma-induced ablation with high precision (sub-
mm range), while surrounding tissue is merely unaffected by this process.
2.2.1 The periscopic probe tip
The central part of the stereotactic neurosurgery device is the periscopic probe
tip. This is the part of the instrument inserted into the patient’s head through a
small hole (about 1 cm) in the cranium. This instrument consists basically of a
lens and a mirror mounted inside of two tubes which can be moved and rotated.
A third tube is added around the two inner tubes for the irrigation and suction
unit (see below).
The focal length of the lens must not be chosen too small, since this would
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Figure 2.6: Geometry of the periscopic probe tip, the part of the laser probe
inserted into the patient’s head.
limit the radius of action of the instrument. The lenses used in the instrument
have focal lengths of f = 38 mm and f = 45 mm. In order to get sufficiently
small focal spot sizes for ignition of a plasma-induced spark, the diameter of the
lens was chosen to 2.8 mm. The lens is mounted at the end of the inner tube
of 0.1 mm wall thickness (Fig.2.7). This inner tube has an outer diameter of
3 mm. At the end of the second tube surrounding the first one, a 45◦ mirror
is mounted to deflect the beam by 90◦ out of the axis of the instrument. By
changing the distance between lens and mirror, the distance of the focal point to
the instrument’s axis is adjusted. By rotating this tube (4.3 mm outer diameter,
0.15 mm wall thickness) the focal point (point of ablation/coagulation) can be
rotated around the axis of the instrument. By moving both tubes together the
third dimension can be accessed. With this setup a cylindrical volume of 50 mm
diameter and 40 mm height can be achieved.
In stereotactic functional neurosurgery very thin needles are used. Their small
diameter reduces the risk of damaging upper layers of the brain passed with the
instrument. Therefore, the part of the stereotactic laser neurosurgical instrument
inserted into the patient’s head is designed with small diameter. Unfortunately
the smallest achievable size of a focal point w0 increases with decrease of the
input beam diameter w:
w0 =
λf
piw
(2.1)
Additionally, the spot size increases with an increase of the focal length f of
the used lens.
CHAPTER 2. STEREOTACTIC LASER NEUROSURGERY 14
2.2.2 Irrigation and suction
Figure 2.7: Schematic drawing of the tube system used for delivery of the laser
light to the tissue in stereotactic laser neurosurgery [35]. The arrows indicate the
flow of irrigation liquid in the space between the tubes.
An irrigation and suction unit is integrated into the probe. Between the inner
tube (outer diameter 3 mm) and the outer tube (inner diameter 4 mm) irrigation
liquid is pumped into the operational cavity. A jet is integrated, so that the liquid
is cleaning the mirror constantly. In parallel the liquid passed by the high energy
laser beams is changed rapidly in order to avoid thermal lensing effects caused
by absorption induced heating of the liquid. Heating would lead to a gradient in
the refractive index of the liquid and the beam could not be focused down to the
required size. A third tube (5.5 mm outer diameter, 0.2 wall thickness) is added
to the system in order to enable the suction of the liquid (Fig.2.7). Therefore
5.5 mm is the outer diameter of the part of the surgical instrument inserted into
the patient’s head. The irrigation system is equipped with a pressure control.
This is necessary because the brain is sensitive to pressure variations [36].
2.2.3 Probe control
The movement of the probe is done with computer controlled stepper motors. Be-
cause the motors are very bulky and heavy they are mounted in an external case.
The movement is transmitted to the instrument by flexible axles. The step-size
of the setup is 2 µm and 0.18◦ for the rotation. The maximum rotational velocity
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would be 180 rounds per minute. The actual velocity used for experiments is 30
rounds per minute. The ablation experiments were done with a maximal step
frequency of 1.5 kHz.
Figure 2.8: Prototype of the stereotactic probe, mounted to a stereotactic system.
2.2.4 Detection unit
In the first design of the laser probe a confocal laser scanning microscope was
integrated into the probe (Fig.2.8). The microscope measured the reflected light
of each single point and generated an image calculated from these and the position
information. The movement of the probe and a scanning movement of the beam
acquiring 20 points per probe position were digitized by a computer and displayed,
showing the scanned surface. The scanning was done by galvanometric scanners.
The detection was achieved by an avalanche photo diode (APD). As a point-
source an argon laser emitting 25 mW was used. The laser light was coupled
into an optical fiber and transmitted to the probe. This confocal microscope was
assigned for the detection of the blood vessels. The detection of blood vessels is
of great importance in order to avoid their damage during surgery. Due to the
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minimal invasive access of the method a quick interaction is not possible without
opening the head of the patient. Therefore, it is important to detect vessels and
close them by coagulation before they are ablated. The obtained images did not
show the blood vessels with the required reliability, because the intensity signal
of a confocal microscope strongly depends on focusing conditions. Thus, a refined
detection is required.
Another reason for the requirement of a refined detection mechanism is the
fact that the precision of the setup cannot be exploited by just using MRI or
CT data. The resolution of these methods is limited to an order of mm. The
precision of ablation, in contrary, is in the range of 50 µm. A detailed analysis of
the tissue during surgery would increase precision and therefore minimize harm
to the patient, because the security region ablated around the actual tumor could
be minimized. This is impossible with a simple reflective confocal microscope,
because the signal is affected by several influences like attenuation by tissue in
the optical pathway, debris on the optics or out-of-focus conditions.
Previous experiments with a confocal fluorescence microscope were done by
M. Zenzinger et al. [37]. With this setup, detection of cancerous tissue using flu-
orescent dyes was possible. The overall fluorescence signal was measured without
using spectroscopic techniques. Blood vessels were not taken into consideration.
However, due to the special fluorescence characteristics of blood, additional de-
tection of blood vessels is likely to be possible with the stereotactic setup.
In this work, a completely new approach is presented. Detection and discrim-
ination of tissue types is done by making use of autofluorescence spectroscopy.
The complete spectrum emitted by the tissue is taken into account. Since dif-
ferent tissue types have characteristic autofluorescence spectra, each spectrum
contains much more information than the overall fluorescence intensity detected
by the devices described above.
Chapter 3
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The ability to spectrally analyze and spatially resolve absorption and fluores-
cence signals allows two different tasks. First, it can provide information for de-
tection and monitoring of physiological states of tissues, including disease; second,
it can lead to functional imaging. In functional imaging a property (metabolic
state, type of tissue) of the specimen is displayed, not just an optic property
(reflectance, fluorescence intensity). Imaging in tissue is always degraded by the
strong optical scattering in biological tissue. Thus, any imaging technique must
discriminate in favor of the unscattered ”ballistic” light signal (which is usually
extremely weak). A good possibility is the use of spectroscopic techniques, as the
spectrum of the emitted light is merely affected by scattering.
A tumor causing clinical symptoms is normally large enough to be localized
by conventional methods like X-ray imaging, CT, MRI, palpation or endoscopy.
As the chance to treat a tumor decreases with time, an reliable detection of
early-stage lesions is needed. These early stages of malignant tumors are of-
ten not accessible by conventional techniques. For many kinds of cancer there
is no reliable detection method available. For example, small papillary lesions
in the bladder are difficult to detect by white light cystoscopy. This requires
random tissue biopsy in order to test for preexisting or recurrent diseases after
treatment. These problems and the improvement of new light sources (especially
lasers), optical fibers, medical endoscopes, and detectors led to the development
and evaluation of fluorescence spectroscopy and imaging for detection, staging
or characterization of malignant and premalignant lesions. The likelihood for
successful treatment and reduced complications can be significantly increased if
primary and recurrent tumors can be detected at early stages. The concept of
optical biopsy helps finding lesions by optical measurements while no removal of
tissue is needed. If the premalignant sites cannot be found directly, it may help
find suspicious sites for biopsy. Advantages of the spectroscopic method are the
sensitivity, especially for point measurements, the suitability for tissue surfaces
and the applicability in a minimal invasive surgery environment.
In vivo and ex vivo characterization of biological samples by fluorescence imag-
ing and fluorescence spectroscopy has been well established over several decades
[38, 39]. The method is based on the localization of fluorophores (fluorescent
molecules) in tissue and cell structures. Fluorescence microscopy is routinely
used for histology [7, 40]. In vivo techniques are, for example, used for the
guidance of surgical resections. The first studies using Light Induced Fluores-
cence Spectroscopy (LIFS) were conducted by Policard et al. in 1924, reporting
fluorescence (attributed to endogenous porphyrins) of tumors illuminated with
UV/violet light. In 1942 Auler et al., Banzer et al., and Figge et al. reported
red fluorescence after giving exogenous porphyrins to animal tumors. Moore was
CHAPTER 3. FLUORESCENCE 19
the first to report improved detection of brain tumors in vivo with the use of
fluorescin. The problems with exogenous dyes, like photosensitized skin, and
independent developments in autofluorescence spectroscopy induced further re-
search on spectroscopy. The goal of this research was to characterize tissue by
using the spectral information from endogenous dyes. Pioneer work on this field
was done by the groups of Protio, Alfano [41] and Yang with in vitro and in vivo
studies on human and animal tumor autofluorescence.
Kriegmair et al. proposed the use of 5-ALA-induced PpIX fluorescence for di-
agnosis in the bladder [42]. In vivo fluorescence techniques had significant impact
on the development of Photo Dynamic Therapy (PDT) treatment. Visualization
plays an important role in the development of PDT, because of the ability of
getting direct information on the pharmacokinetics of the photosensitizers by
monitoring their uptake and photobleaching.
There is an increased interest in fluorescence-based techniques in oncologi-
cal applications in order to detect and characterize premalignant or malignant
lesions by in vivo fluorescence spectroscopy and imaging. Several papers have al-
ready reviewed several aspects in this field. Richard-Kortum and Sevick-Muraca
[14] have discussed several spectroscopic methods, including fluorescence, from
a quantitative point of view. B.C. Wilson described oncological in vivo appli-
cations of fluorescence spectroscopy, which were classified according to the type
of fluorophores and the used instrumentation [43]. One classification is done in
terms of the light detection scheme and the used light source. One type of light
detectors are time gated and/or time resolved detectors using light pulses or cw
(continuous wave) devices.
In cells, various numbers of fluorescent dyes are present, providing information
about the biochemistry of the cell. For a single photon-activated compound the
fluorescence intensity Im follows a monoexponential decay with time t resulting
from an impulse of incident light.
Im(t) = I0
α(C(r))
τ
L exp
(
− t
τ
)
(3.1)
I0 is the incident intensity,  the extinction coefficient of the fluorophore at
the excitation wavelength, (C(r)) the concentration of the sample, α the quantum
yield at the emission wavelength, τ the lifetime of the sample and L the distance
covered in solution. The lifetime τ is the mean time between the absorption of
an extinction photon and the remission of a fluorescent photon.
The steady state intensity is obtained by integrating over all remission times.
Im =
∫ ∞
0
I0
α(C(r))
τ
L exp
(
− t
τ
)
= I0α(C(r))L (3.2)
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This is a simple function dependent on the sample concentration, absorption
coefficient, and quantum yield. The remitted intensity is determined by the
environment of the sample which has an impact on the extinction coefficient  and
the quantum yield α, and the local concentration. Intensity measurements are
affected by the attenuation of excitation and fluorescent light while propagating
in tissue. In the presented experiments, the absolute intensity information is
suppressed by simply using relative intensities.
Figure 3.1: Multipolar nerve cell stained with pyridin-silver-goldchlorine [44].
While looking at biological samples, the imaging quality is often limited by the
lack of contrast, not by poor resolution. A classical method of gaining contrast
and information is the use of dyes, which stain the different parts of the sample
in different ways (Fig.3.1). In pathology, the sample is cut into very thin slices
and stained with different types of dyes. Thus, the sample is seen in different
colors, due to the changed reflective properties of the sample. This method is
applicable only in fixed tissue, not in vivo.
Fluorescent dyes work slightly different. In the case of fluorescent dyes, the
dye emits light in a characteristic manner, i.e. the emiting wavelength differs from
the wavelength of absorbed light. The molecules of exogenous or endogenous dyes
in biological samples are soluble macromolecules in the cell. In the first step a
molecule absorbs the energy E = hν ′ of a photon. Typically, the molecule gets
excited from its ground energy level S0,0 to the first excited state S1,v (Fig.3.2).
By inner conversion, the molecule relaxes into the S1,0 state. This state has a
lifetime of the order of 10−9s. A photon is emitted by the molecule, transiting
from the excited to the ground state. The energy hν of the emitted photon is lower
than the energy of the absorbed photon (ν < ν ′). In fluorescence microscopy this
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Figure 3.2: Typical term scheme of a molecule.
property is used to separate the exciting light (in our case from a laser), which
illuminates the sample, from the light emitted by the observed tissue sample.
An edge filter or, as in our setup, a dicroic mirror can be used. The edge filter
absorbs light higher/lower than a certain frequency. The dicroic mirror consists of
a dielectric coating reflecting light with the frequency of the laser and transmitting
the remaining frequencies. With this setup it is possible to separate the exciting
frequency from the light for analysis.
There are different types of fluorescence dyes (fluorophores):
• Exogenous dyes
• Fluorophore precursors
• Endogenous fluorescence dyes
Each of these classes of fluorophores has distinct limitations and advantages for
different applications.
3.1 Exogenous fluorescence dyes
In the 1950s, the accumulation of HP (hematoporphyrin) in various types of can-
cer was reported. From this, HpD (hematoporphyrin derivative) was developed
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for the localization of cancer in various organs, including esophagus and cervix
[45] and for the characterization of suspicious head and neck lesions. Some of
these early studies were very successful in observing cancer in an advanced stage.
Current work focusing on early stage cancer and premalignant lesions is not that
successful. The early studies were conducted under direct-viewing conditions.
Dorion and Kinsey therefore used photoelectronic detectors in order to gain sen-
sitivity. Based on their work, many other studies using fluorescence diagnostics
were conducted. As most of the exogenous dyes have been initially developed for
the use as photosensitizers for Photo-Dynamic Therapy (PDT), they do not yield
optimum results in fluorescence diagnostics. The selectivity of these fluorophores
initially developed for PDT is rather poor. Lam et al. [46] found by stepwise
decrease of the dose of HpD (they tried to reduce the photosensitivity of the
skin) that early lesions could be detected with high accuracy with the detection
of autofluorescence.
In the work presented here, only the autofluorescence of the observed tissue
was used. It was possible to confirm the suitability of the method proposed by
Lam et al. for detection of different types of tissue. However, for the monitoring
of the concentrations of the photosensitizer agents in PDT, the exogenous dyes
can be very helpful. Improved results might be achieved with a combination of
exogenous and endogenous dyes compared to just using one of the methods.
Exogenous dyes can be administered to the patient e.g. by injection or oral.
There are various advantages of exogenous dyes. The photo-physical properties
can be selected and are well known. Thus, the pharmacokinetics can, in princi-
ple, be chosen to optimize targeting. Another advantage is that the fluorescence
signal intensity can be much higher compared to autofluorescence, which simpli-
fies instrumentation. Exogenous dyes can have different properties which can be
used for diagnosis. Some dyes concentrate in cancerous tissues due to the changed
metabolism in cancerous cells. The transport of educts is impaired in cancerous
cells. This higher concentration of dyes can be used to recognize cancerous tissue.
An important question in the context of fluorophores is why they localize more
or less selectively in tumors. Knowledge about the mechanisms of enrichment
would enable the development of optimized fluorophores. Another mechanism
responsible for higher concentrations of fluorophores in tumor tissue is that the
quality of blood vessels in tumors is poor and the vessels are leaky, leading to
an early release of systemically administered drugs through the vascular wall. In
combination with a poor lymphatic drain this leads to a higher uptake and re-
tention of fluorophores. One of the main disadvantage of exogenous dyes is that
their handling is difficult. Normally a very strict time-table has to be followed in
order to obtain good results. The main drawback of exogenous dyes are the side
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effects. For example, dyes (e.g. acridin orange [4]) that bind to the DNA are not
applicable in vivo due to their carcinogenic potential. In vitro very good results
can be achieved. Therefore they can be used for the characterization of tissue
samples obtained in a biopsy.
3.2 Fluorophore precursors
Fluorophore precursors are substances inducing the production of fluorescent dyes
in the cell. 5-ALA (5-aminolevulinic acid) for example induces the production of
PpIX (protoporphyrin IX) in the cell. 5-ALA is a precursor in heme biosynthe-
sis, introducing a corresponding increase in heme biosynthesis. The penultimate
step in this synthesis is the fluorophore PpIX. The last step in heme synthesis
is the incorporation of iron into PpIX and takes place under the action of the
enzyme ferrochelatase in mitochondria. In tumors, the activity of this enzyme is
lowered/reduced and therefore the penultimate product PpIX is enriched [47, 48].
Another factor for tumor selectivity is the low penetrability of 5-ALA through
intact skin and cell membranes due to its hydrophilic property. In contrast, skin
tumors have an increased permeability of, leading to a higher concentration of
5-ALA in the tumor when applied locally. As this is an effective photodynamic
sensitizer it was primarily used in photodynamic therapy (PDT). Photodynamic
therapy involves the systemic administration of a photosensitizer that visualizes
tumors and its subsequent activation by light of an appropriate wavelength. This
induces photochemical reactions which cause photodamage to the tumor. The use
of 5-ALA for PDT treatment has been reviewed by Peng et al., who also summa-
rized the clinical and developmental status of fluorescence diagnosis with 5-ALA
[49]. The concentration of PpIX induced endogenously from exogenous 5-ALA
in tumors reaches its maximum from one to six hours after systemic administra-
tion of 5-ALA. During subsequent investigation, the applicability of fluorescence
detection and localization of dysplasia and early stage cancer has been investi-
gated. The contrast caused by PpIX depends on several pharmacological and
physiological factors that can alter the distribution and kinetics, the local rate of
heme biosynthesis and the rate of clearance of PpIX [50]. The mechanisms of the
accumulation of porphyrins in tumors is not clear yet. Even in the same patient,
the contrast can vary with time and from lesion to lesion. Varying concentra-
tion in premalignant and malignant tissues may be traced back to differences in
the cell or the changed micro-environment. It can be administered oral or intra-
venous, while topological application or instillation can be used in dermatology
or in hollow organs like the bladder. Typically, the period of time from a single
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dose application to peak fluorescence is about seven hours. The peak ratios of
tumor to normal tissue are in the order of 10:1 [51]. The 5-ALA-induced PpIX
fluorescence increases and decreases faster in tumor tissue than in normal tissue.
Therefore the time of observation is very important. The specific PpIX distri-
butions inside a cell have to be taken into account. Certain variations of 5-ALA
(e.g. lipophilic derivatives for increased tissue penetration) are used in order to
modify the distribution of PpIX in the tissue.
3.3 Endogenous fluorescence dyes - Autofluo-
rescence
Endogenous fluorescence dyes are responsible for the autofluorescence of tissue.
Transitions between energy levels of molecules intrinsic to the tissue are excited
and the emission is detected. The main advantage of endogenous fluorophores
is the lack of side effects since only substances intrinsic to the cell are used.
The tissue observed in vivo is not affected. The disadvantages of autofluores-
cence are the low light levels compared to the use of exogenous dyes. But this
problem/drawback can be solved by refining the used detection technique. In
principle, there is enough information in the autofluorescence signal for charac-
terization of the tissue.
Figure 3.3: Absorption (left) and emission (right) spectra of several substances
in a cell [43].
The most frequent molecules of a cell are either located in the structural ma-
trix of the cell or part of the cell metabolism. The most important fluorophores
in the cell matrix are collagen and elastin, the fluorescence of which is a result
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of cross-linking between amino-acids [14]. Flavin and the reduced form of nicoti-
namide adenine dinucleotide (NADH, only the reduced form is fluorescent) are
the fluorophores involved in the metabolism. Other fluorophores are aromatic
amino acids (tryptophan, tyrosine, phenylalanine), porphyrins and lipopigments
(ceroids, lipofuscin) that are the endproducts of lipid metabolism. In addition,
red porphyrin fluorescence due to bacteria may be detectable in certain body sites
(not the brain) and lesions. Fig.3.3 shows the excitation and emission spectra
of various endogenous tissue fluorophores. Any given tissue contains a charac-
teristic mixture of fluorophores. As in cancerous tissue the concentration varies
compared to normal tissue, the autofluorescence properties can be used to detect
cancer.
The characteristics of tissue depend on the following points:
• Each fluorophore has special excitation and emission characteristics.
• A given tissue contains a mixture of various fluorophores in different con-
centrations.
• The distribution of the fluorophore concentrations is not constant in tissue.
Especially it varies with depth in the tissue due to the layered structure
(e.g. mucosa, submucosa, muscularis). Each of these layers has a different
fluorophore composition. Optical sectioning (with a confocal setup) has to
be used to separate the layers and to suppress signals from other layers.
The detectable changes of fluorescence signals in cancer tissue due to metabolic
or morphological changes vary with the used wavelengths for excitation and de-
tection. The autofluorescence of premalignant lesions or early cancer can alter
some tissue characteristics:
• The concentration and spatial distribution of fluorophores.
• The metabolic status of the cell and the fluorophore (e.g. only the reduced
form of NADH is fluorescent).
• The biochemical and biophysical environment of the tissue. This can alter
quantum yield, position of the spectral peaks and the width of the peaks.
• The tissue structure, like mucosal thickening or the complete loss of layered
structure.
• The altered concentration and distribution of hemoglobin and other chro-
mophores changes the wavelength-dependent attenuation.
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The alteration of these signals by metabolic and structural changes influences
the excitation and emission wavelengths of the examined fluorophores. For a given
application, a working combination of excitation and detection wavelengths has
to be found. Some fluorophores (e.g. aromatic amino acids of proteins) can only
be observed in the UV range, while others can be excited with visible light. The
depth penetration increases with wavelength and has its maximum (therapeutic
window) in the infrared (700-1100 nm). For each application or body site there
may be one or more optimal combinations of excitation and emission wavelengths.
These are generally not known and thus have to be determined. This optimization
can be done ex vivo with tissue biopsies or in vivo. The ex vivo optimization has
the advantage of refined spectroscopic and microscopic devices but the spectra
might be changed due to altered metabolic status or the lack of blood supply.
Chapter 4
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4.1 Spectrograph
For our preliminary experiments [28] and the OCSA applications, a spectrograph
based on a prism (the dispersion of the prism) was applied. Fig.4.1 shows the
general setup of such a spectrograph. On the left, a pinhole generates a spot of
light; in our setup this is realized by a pinhole onto which the beam from the
probe is focused. The light is collimated by an achromatic lens (lens 1). Behind
the prism the beam is focused onto the screen/detector by a second achromatic
lens (lens 2).
Figure 4.1: Schematic drawing of the spectrograph. The light from a point source
(light source with pinhole) is collimated onto the prism. Behind the prism the
beam is refocused onto the screen [52].
The central part of the spectroscopic device, the OligoChannel Spectral An-
alyzer (OCSA, see chapter 5), is a prism. Light that crosses a prism is deflected
by an angle δ. Here, the symmetric transition of a beam is described, that means
that α1 = α
′
1 and α2 = α
′
2. In this case, δ is minimal and the following relation
is fulfilled:
γ + δ = 2α (4.1)
With the law of refraction the result is:
sinα1
sinα2
= n =
sin(γ + δ)/2
sin γ/2
(4.2)
or:
sin
γ + δ
2
= n sin
γ
2
(4.3)
The refractive index n is dependent on the wavelength of the light. Thus,
different wavelengths are refracted in different angles. This is called dispersion.
According to equation 4.3 the angle of deflection is dependent on the refractive
index n = n(λ). A beam of light consistent of different wavelengths can be
separated into its spectral components. In our experiments, a prism with a
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Figure 4.2: Deflection of light transmitting a prism. The symmetric case is shown.
dispersion of 3◦ between λ1 = 480 nm and λ2 = 643.8 nm was used. With
the used focusing lens, which had a focal length of 120 mm, an incident angular
deflection of three degrees (corresponding to a wavelength divergence of 163.8 nm)
leads to a beam displacement of 6.3 mm on the detection screen. A wavelength
divergence of 50 nm (which was used in our experiments) results in a displacement
of 1.9 mm on the screen.
4.2 Beam expander
Figure 4.3: Transformation of beam diameter and scanning diameter by a tele-
scope [53].
Beams often have to be transformed to another diameter in optical setups,
e.g. in adaptive optics (AO) setup described in Appendix A, the sizes of the
wavefront sensor and the deformable mirror are not the same. In addition, the
optical elements (wavefront sensor, deformable mirror and the distortion itself)
of the AO system have to be in optically conjugated planes. These are planes in
which beams have equal properties. A parallel beam in one conjugated plane is
parallel in all other conjugated planes. A focal point is transformed to another
focal point, and wavefronts are of the same shape in all conjugated planes. A pupil
can be transformed by an afocal or 4-f-system from one to another conjugated
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Figure 4.4: Transformation of beam angles by a telescope.
plane. Two lenses are arranged at a distance of d = f1 + f2 to form a telescope.
Beam diameter (Fig.4.3) and angle (Fig.4.4) are transformed as follows:
d2 = d1
f2
f1
(4.4)
α2 = arctan
(
f1
f2
tanα1
)
(4.5)
For small angles this can be approximated:
α2 =
f1
f2
α1 (4.6)
4.3 Confocal Microscopy
The tissue is observed by a confocal laser scanning microscope [5] integrated in
the probe [37, 54].
Fig.4.5(a) shows the setup a conventional microscope. The whole object plane
is illuminated and imaged onto the image plane. The optical quality of the
illuminating lens (condenser) is of minor importance for the quality of the image,
since the quality of the image is mainly defined by the quality of the objective
(imaging lens). Fig.4.5(b) and 4.5(c) show setups of scanning microscopes. In
the first case (b) the completely illuminated object is imaged by a point detector
that scans the image plane. In the second case (c) the object is illuminated by a
small spot (point source) and the whole intensity in the image plane is detected.
The scanning microscopes have the advantage of an adjustable size of the imaged
region. Due to the serial acquisition of the data, the data can easily be recorded
by a computer. Electronic image enhancement algorithms can be used. The
imaging properties of the three microscope types ((a), (b), and (c)) are the same.
Compared to conventional setups the confocal system has improved imaging
properties [6]. A general setup of a confocal microscope is shown in (Fig.4.5(d)).
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Figure 4.5: Different types of microscopes: (a) conventional microscope; (b), (c)
different types of conventional scanning microscopes; (d) confocal microscope [5].
The confocal microscope uses a point source and a point detector. In reflection
mode (Fig.4.8) one lens is used for point illumination and point detection. The
advantages of this setup is, that it is self-aligning.
The resolution of a conventional microscope is defined by the diffraction of
the lens. Imaging a point by a lens the the point spread function is an airy-disk
(Fig.4.6):
I(v) = I(0)
(
2J1(v)
v
)2
(4.7)
J1 is the first Bessel function. With sinα, the numerical aperture we get for v:
v =
2pi
λ
r sinα (4.8)
In the confocal setup the point spread function is squared, because the lens
is used twice, first for imaging of the point source onto the observe point, and
second for imaging of this illuminated point onto the point detector. This leads
to the following function:
I(v) = I(0)
(
2J1(v)
v
)4
(4.9)
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Figure 4.6: Airy disk.
Figure 4.7: Experimental contrast transfer values as a function of the spatial
period of a line grating [7].
Fig.4.7 shows, that the ultimate resolution of a confocal scanning microscope
in reflection mode and a conventional microscope are the same, but the contrast
produced by a confocal microscope is higher. For very small pinholes (smaller
than the airy disk produced by a point fluorescent object) and fluorescence imag-
ing, the resolution of a confocal microscope can increase by a factor of
√
2.
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4.3.1 Sectioning
One of the main advantages of a confocal microscope is its optical sectioning
capability. This means that only light from the focal point (Fig.4.8 solid lines)
is able to enter the point detector. Light from other than the focal spot (Fig.4.8
dotted lines) is not focused onto the point detector and does not contribute to the
signal since they are rejected. This is a very important property for our purposes,
as there are many disturbing influences in the operational cavity (plasma sparks,
debris in the path of light), which have to be discriminated in order to obtain an
interpretable signal.
Figure 4.8: Sectioning properties of a confocal microscope [7].
The intensity along the optical axis of the illumination point is:
I(u) =
(
sin(u/4)
u/4
)2
I0 (4.10)
with:
u =
2pi
λ
(
a
f
)2
z (4.11)
Fig.4.9 shows the depth resolution functions dependent on u for conventional and
confocal microscopes. In a conventional microscope (dotted line) the reflected
intensity of a point reflector is proportional to the intensity at this point and
therefore proportional to function 4.10. The depth resolution is given by the
width of the function at half maximum intensity I1/2 = I(u1/2) = 1/2I0. Solving
the equation 4.10 gives a value u1/2 = 5.566. With equation 4.11 a value for the
depth resolution can be calculated from focal length f of the lens and the beam
diameter a:
z1/2 =
2λ
pi
(
f
a
)2
u1/2 (4.12)
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In a confocal microscope the illumination focus is imaged onto the detection
pinhole. The depth transfer function is displayed in Fig.4.9 as a solid line. By the
additional imaging of the illuminated point the point spread function is squared.
This leads to the depth transfer function of the confocal microscope:
I(u) =
(
sin(u/4)
u/4
)4
I0 (4.13)
u is defined in equation 4.11. In this case, the width at half maximum is u1/2 =
4.008. The depth resolution is improved by a factor of 1.39. These are the
calculations for the transfer function of a single point. For a three-dimensional
object, the differences are bigger because the neighboring points have to be taken
into account. In the case of a conventional microscope, the same brightness is
detected from out-of-focus points as from objects in the focus. However, the light
from out-of-focus points does not carry information. If for example a mirror is
moved along the optical axis (the distance to the lens is changed), the detected
intensity does not change with distance.
In contrast, the confocal microscope works different. As in the case of the
mirror there is only light from the focal point detected. Signal can only arrive
at the detector if the mirror is in the focal plane. Light from outside the focal
point is rejected. This is an important property for detection of the spectrum
of a single point in the human brain, surrounded by other points emitting or
reflecting light.
In order to reach even better suppression of disturbing signals the use of
two-photon microscopic/spectroscopic technique is possible. In two-photon spec-
troscopy a short pulsed laser is used for excitation. Thus, very high intensities
are reached. With these very high intensities it is possible to excite energy levels
with the energy of two photons. As the excitation probability increases quadratic
with intensity, in two-photon spectroscopy the Point Spread Function (PSF) is
further improved compared to normal microscopy. The excitation wavelength
can be filtered very easily because the emitted photons have higher (up to twice
as much) energy than the excitation wavelength. Confocal and two-photon mi-
croscopy can be combined in order to further increase the PSF and suppression
of disturbances.
4.4 Laser-Tissue interaction
Interaction between tissue and laser can be characterized by the mode of opera-
tion. Dependent on the intensity of the laser and the duration of the interaction,
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Figure 4.9: Depth resolution of a confocal (solid line) and a conventional (dotted
line) microscope [7].
different types of laser-tissue interactions are distinguished [55, 56]: chemical,
thermal, photo-disruptive or plasma-induced interactions (Fig.4.10). For stereo-
tactic laser neurosurgery plasma-induced laser ablation by a picosecond laser is
used.
4.4.1 Photo-chemical interaction
For photo-chemical interaction of light with tissue the presence of an exogenous
substance, a photosensitizer is needed. This is a substance (e.g. Hematoporphyrin
derivative (HpD)) that develops its toxic properties after irradiation with light of a
certain wavelength. The main advantage of this Photo-Dynamic Therapy (PDT)
is that diffusely growing tumor cells can be accessed and destroyed, because the
used photosensitizers accumulates in tumorous tissue selectively. Photochemical
interactions take place at very low power densities (typically 1 W/cm2).
4.4.2 Thermal interaction
The thermal interaction of light with tissue is based on simple heating of the
irradiated volume. The electro-magnetic energy is transformed to heat by excita-
tion of the vibronic and rotatory states of the molecules. The excited molecules
transfer their energy into heat by inelastic scattering with neighboring molecules.
Pulsed lasers and lasers emitting continuous waves can be used (typical pulse
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Figure 4.10: Laser-Tissue interactions [56].
durations: 1 µs to 1 min, typical power densities: 10-106 W/cm2). The result-
ing temperatures depend on the duration and intensity of the laser light. The
optimal laser (wavelength) depends on the absorption properties of the tissue.
A commonly used laser for thermal interaction is the CO2 laser emitting light
at 10.6 µm. The light is absorbed at the surface of the tissue. The absorption
coefficient of water depends on the wavelength of the radiation (Fig.4.11). Ab-
sorption is minimal between 700 nm and 1100 nm. Light is able to penetrate
water (a main component of the cell) very deep, therefore this region is called
’therapeutic window’.
The radiation of the laser (Nd:YAG; 1.064 µm) used for coagulation in stereo-
tactic neurosurgery penetrates the tissue up to a few mm. It is especially suitable
for the required coagulation of the blood vessels in neurosurgery, because the ab-
sorption coefficient of blood is 100 times higher than that of brain tissue, i.e.
blood is heated up stronger due to the higher energy deposition. This property
enables the coagulation of blood vessels in the brain without causing bleedings.
It is difficult to use the right amount of energy due to the heat conduction in
the tissue. The appropriate energy level has to be chosen because heat diffusion
affects surrounding tissue (Fig.4.12). Exposure time, pulse length, and repetition
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Figure 4.11: Optical attenuation coefficient (in mm−1) for water [57]. For wave-
lengths between 700 and 1100 nm the absorption is very low, the so-called ”ther-
apeutic window”.
rate of the laser have to be chosen to fit the current operation conditions, which
depend on the diffusion properties, thermal conductivity, and the specific heat of
the tissue. Due to the isotropic property of heat diffusion, the accurate coagu-
lation of the tumor seems to be nearly impossible, even if the exact optical and
thermal properties of the tissue are known. Thermal effects caused by irradiation
are shown in Fig.4.12 and listed in Table 4.1.
Figure 4.12: Location of thermal effects of laser radiation in tissue.
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Temperature Effect in the tissue
45◦ C Hyperthermia, shrinking due to changes in the cell membranes
50◦ C Lower activity of enzymes, cell immobility
62◦ C Coagulation, denaturation of proteins causes coagulation
80◦ C Permeabilization of membranes
100◦ C Vaporization, thermal decomposition (ablation)
over 150◦ C Carbonisation
over 300◦ C Melting
Table 4.1: Thermal effects of laser radiation.
4.4.3 Photo ablation
Chemical bonds are broken by very high energies of the used photons (several
eV ) [55].
hν+AB −→ A+ B
Wavelengths in the UV are needed, therefore eximer-lasers are used (for example
an ArF eximer laser with a wavelength of 193 nm (photon energy: 6.4 eV ). The
photon energy exceeds the dissociation energy of many chemical bonds (C = C:
6.4 eV ; O−H: 4.8 eV ; C−C: 3.6 eV )). These lasers are used for the ablation of
corneal tissue in refractive corneal eye surgery. Typical lasers for photo ablation
have pulse durations of 10-100 ns and the used power densities are in the order
of 107-1010 W/cm2.
4.4.4 Plasma-induced ablation
Optical breakdown occurs if power densities exceed 1011 W/cm2 in fluids and
solids or 1014 W/cm2 in air. With these densities, a plasma, i.e. a high ionized
state, is induced, and a plasma spark is visible. There are two possibilities to
initiate the generation of a plasma: either with pulses in the nanosecond range
or with pulses in the pico- and femtosecond range. With nanosecond pulses
the tissue initially heats up to over 1000 K and thermal ionization takes place.
With pulses in the pico- and femtosecond range, the high photon density enables
coherent absorption of several photons providing enough energy for multi-photon
ionization. In both cases some (so-called ’lucky’) electrons absorb further energy
from the radiation field by inverse bremsstrahlung. Larger amounts of atoms
and molecules are ionized by these accelerated electrons, therefore initiating an
avalanche effect. Within a few picoseconds, a plasma with very high electron
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Figure 4.13: EM picture of an ablation pattern (size: 1 mm3) in brain tissue of a
pig. Ablation is done with a ps-laser. The picture shows the accuracy of ablation
and the little damage to the surrounding tissue.
density (1021 cm−3) is generated. The correlation between the minimal energy
density %th and pulse duration tp is the following:
%th ∝
√
tp (4.14)
Plasma generated in water (tissues with high water contents are effected as
well) induces shock waves. These shock waves propagate with twice the velocity
of sound for the first 100-200 µm, after which they propagate with the velocity
of sound (1480 m/s). Upon vaporization of the liquid at the plasma, a cavity is
formed. The radius of the damaged area is of the same radius as the maximum
radius of cavitation bubbles, therefore implying, that the forming of cavitation
bubbles is the process mainly responsible for ablation. The equations 4.14 shows,
that with shorter pulse durations the energy needed for generation of a plasma
and the region affected by the process decrease. For precise ablation of tissue,
short pulses with energies near the threshold energy have to be chosen. With
plasma induced ablation it is possible to locally resect small pieces of tissue with
high precision (Fig.4.13). With the used laser system the ablated volumes have
side lengths of about 50 µm.
4.5 Laser Systems
In stereotactic laser neurosurgery different laser systems are required. Some lasers
used for medical applications are listed in Table 4.2. For diagnosis a continuous
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wave (cw) HeCd laser is used. For coagulation and ablation infrared lasers are
applied. The optical quality of a laser beam is expressed by the factor M2. This
factor describes the extent of the radius(w0)-divergence(θ) product of the beams
compared to an optimal Gaussian beam. For an ideal laser we have:
w0θ =
λ
pi
(4.15)
and for a real laser:
w0MθM = M
2λ
pi
>
λ
pi
(4.16)
Laser type Wavelength (nm) Typical pulse duration
Argon ion 488/514 cw
HeNe 633 cw
HeCd 325/442 cw
CO2 10600 cw or pulsed
Dye lasers 450-900 cw or pulsed
Nd:YLF 1053 100ns-250µs
Nd:YAG 1064 100ns-250µs
Nd:YLF 1053 30ps-100ps
Nd:YAG 1064 30ps-100ps
Ti:Sapphire 700-1000 10fs-100ps
Table 4.2: Some laser systems used in medical applications.
4.5.1 Laser for diagnosis
In our setup, the diagnostic laser is a HeCd laser (IK 5652R-G, Kimmon electric
co., ltd, Tokyo, Japan), which delivers 100 mW at the used wavelength of 442
nm. In addition, the laser delivers 30 mW in the UV at 325 nm. The emitted
wavelengths can be selected (no emission, 442 nm, 325 nm, or 442 nm and 325
nm) with a shutter/wavelength-selector at the laser aperture.
4.5.2 Lasers for ablation
As for plasma-induced laser ablation high energy pulses with short durations and
high repetition rates are needed, an appropriate laser system is required [58]. Two
laser systems have been used for stereotactic laser neurosurgery applications:
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The Nd:YLF laser system
This Nd:YLF laser system was developed in our department. The system delivers
laser pulses with a duration down to 30 ps and energies up to 1 mJ with a
repetition rate of 1 kHz. The wavelength is 1053 nm and is therefore within the
scope of the therapeutic window. That means the attenuation in tissue at this
wavelength is rather low, allowing penetration of the tissue. This laser consists
of two parts: an oscillator and a regenerative amplifier.
Figure 4.14: Schematic drawing of a Nd:YLF ps-laser system. OC, AOM, BP,
L1, Nd:YLF, CO and DL (upper half) form the Oscillator. CM1, PC, QWP, P,
Nd:YLF, A and CM2 form the ReGen.
In the oscillator and the regenerative amplifier the active medium is an Yttrium-
Lithium-Fluoride-crystal dotted with 1.5 % of neodymium3+-ions. Light pulses
are formed in the oscillator by mode coupling with an acusto-optic modulator
(AOM). These pulses of duration of some picoseconds have energies of about 0.2
nJ .
In the upper part of Fig.4.14 the oscillator is shown. Ultra short pulses with
a low energy (30 mW ) are generated with a repetition rate of 160 MHz. The
backplane of the Nd:YLF crystal is one of the two resonator mirrors. The laser
diode (LD) pumps the crystal longitudinally. The TEM00 mode is favored in this
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setup. The AOM generates an optical grating. An 80 MHz signal, applied to
the AOM, generates a train of short pulses with durations of about 25 ps. The
autocorrelation system allows the check of the pulses’ width. With the brewster
plate (BP) the 1053 nm transition is selected. At the half wave plate (HWP) the
polarization vector (160MHz, 0.2 nJ) of the pulse train is rotated by 90◦. Mirror
M3 (4% reflectivity) and the polarizing beam splitter (P) injects the pulses into
the regenerative amplifier (ReGen). The ReGen is shown in the lower part of
Fig.4.14. It consists of two 76 mm Nd:YLF rods, pumped by xenon lamps and a
Pockels cell (PC). The cavity is formed by the two highly reflective mirrors (CM1,
CM2) with a curvature of 1 m. The Pockels cell, a LiNbO3 crystal, provides half
wave retardation per round-trip by applying 2 kV voltage. In combination with
the half wave retardation of the quarter wave plate (QWP), a selected oscillator
pulse is seeded and trapped in the ReGen unit. After about 100 round trips the
Pockels cell is switched to 0 kV , leading to loss of retardation. The polarization
vector is rotated by 90◦ by twice passing the quarter wave plate (QWP). The
amplified pulse is then reflected at the beam splitter (P) and dumped out of the
ReGen. The pulse energy can be increased up to 1 mJ by amplification. The
aperture (A) restricts the laser to the TEM0,0 mode. 96 % of the dumped pulse
are reflected out of the laser system by mirror M4 and can be used for tissue
experiments.
This laser system needs high power electrical supply (three phase supply with
400 V , 64 A) and water (at least 50 l per minute) for cooling of the xenon lamp
pump heads. For the first experiments in the animal facility in Leuven (Belgium)
[59] an extensive installation had to be done before the experiments could be
conducted.
The Nd:YAG laser system
The second laser system evaluated was the HARP picosecond laser from Time-
Bandwidth. This is the actually used laser for ablation in stereotactic laser
neurosurgery. This laser consists of three parts: the oscillator, the regenerative
amplifier, and an amplifier. All laser media are pumped by laser diodes.
The oscillator is realized by a SESAM (semiconductor saturable absorber
mirror) realizing a passive mode coupling and a Nd:YVO4 diode pumped laser.
The mirror opens after saturated absorption, and a pulse of 10 nJ is emitted.
The second unit is a regenerative amplifier. Its laser medium is pumped by
a 20 W laser diode. A Pockels cell switches the cavity with a repetition rate of
4 kHz from dumping to seeding. The output power of this ReGen is 1.6 W .
The third unit is not a laser, because no end mirror is implemented. This unit
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serves as a four pass amplifier. The active medium is a Nd:YAG crystal with a
diameter of 4 mm and a length of 105 mm. The rods are pumped by pentagonal
laser diode arrays with an electrical power of 1.4 kW . After four passes through
the amplifier the pulses are amplified to an output power of 10 W . The laser
delivers a beam with M2x = 2.1 and M
2
y = 2.9 in x- respectively y-direction.
The advantage of this setup is that for supply only regular 230V /16A sockets
are required. The cooling is done by closed water cooling, which transmits the
energy to the surrounding air. Thus, no water connection is needed.
4.5.3 Laser for coagulation
For the coagulation of blood vessels an industrial laser system was used. A lamp
pumped Nd:YAG laser with a wavelength of 1.064 µm produces a typical output
power in the TEM00 mode of 28 W . As the laser is intended for industrial use
the beam quality is not optimal (M2 ≈ 1.3, M gives the factor to which extent
the real beam is bigger than a theoretical Gaussian beam). This laser has to be
cooled with a double circulation water cooling.
4.6 Beam guidance
This section describes how the laser radiation is applied to the patient. In the
neurosurgery facility of the University of Cologne, the laser systems are installed
in a room near the operating theatre. Therefore, a distance of 10 m has to be
spanned. The distance is bridged using an optical tunnel with beam guiding
optics. The use of optical fibers is not possible due to the high intensities of the
laser beam. In mono-mode fibers the energy density would be far too high and
the fiber would be destroyed. As an alternative, a thick optical fiber could be
used, but in this case the beam quality would degrade to such an extent, that the
beam could just be focused down to a size of the optical fiber [60]. Its focal spot
size would not be sufficiently small to get plasma-induced ablation in the tissue.
The laser beam is guided to the laser probe by an articulated mirror arm.
If different beam diameters are required, a telescope has to be used. The
best choice for this application is to use a focus-free Galilei telescope in order
to avoid the generation of plasma sparks inside the telescope. The articulated
mirror arm has to be adjusted very precisely, otherwise no radiation can pass the
arm. For the online-correction of the deviations due to movements of the arm,
an automated beam-adjustment is integrated into the arm [61]. The position of
the beam is detected by four-quadrant diodes and, if necessary, readjusted by
motor-adjustable mirrors.
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4.7 Software engineering
For the control of the setup and display of the data, a C++ program was de-
veloped using the QT-libraries [62, 63]. A detailed description of the program is
given in chapter 5.3.
Chapter 5
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As described in chapters 2 and 3, the OligoChannel Spectrum Analyzer (OCSA)
was developed in order to overcome the disadvantages of the OMA, because high
signals and long exposure times are not available in neurosurgery [64]. Therefore,
a combination of the two types (point spectroscopy, analyzing the spectrum of
one point in the sample [48] and fluorescence imaging [47]) of fluorescence de-
tectors has been developed: the OCSA [65, 66]. The aim is to do fast (up to
MHz-range) and sensitive analysis. We try to keep the advantages (sensitivity,
speed, and significance) of both systems, while overcoming their disadvantages.
5.1 Analysis
Results in literature [27] and results of our own experiments [28] show, that there
is enough information in the autofluorescence spectra of the different types of
tissue for reliable distinction between them. The only problem is to access this
information. The following access is widely used:
For a certain application (e.g. the distinction between healthy and cancerous
lung tissue) spectra of the different tissue types are obtained.
Figure 5.1: Spectra of normal (BN) and cancerous (BC) human breast tissue.
The tissue is illuminated with an excitation wavelength of 488 nm (Argon laser)
and the emitted spectrum is recorded by an OMA. The main maximum is shifted
and the side maxima are reduced in cancerous tissue.
As an example, the autofluorescence spectra of normal (BN) and tumor (BC)
human breast tissues are shown in Fig.5.1 [27]. The endogenous fluorophores in
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the tissue are photoexcited at 488 nm and observed from 500 nm to 700 nm.
The main spectral peaks are located at 514 nm for normal and at 517 nm for
tumor tissue. In addition, there are two subsidiary peaks at 556 nm and 592 nm
in healthy tissue, whereas the spectrum of tumor tissue shows a monotonic de-
crease with no clear side maxima. In the observed sample the location of the
main maxima varies at different points in the sample from 514 nm to 516 nm for
normal tissue and from 517 nm to 519 nm for tumor tissue. Fluorescence studies
have shown that the spectral maxima of proteins which contain fluorophores are
shifted to higher wavelengths after gaining negatively charged ions [67]. There-
fore, analysis of the location of the main maxima can provide information about
the type of tissue. Another possibility to access information inside autofluores-
cence spectra is to examine the side maxima: The tissue is healthy if side peaks
can be found. A method described in literature is the division of the intensities
at 556 nm and 592 nm by the intensities at 550 nm and 580 nm. This gives
values of 0.91 and 0.94 for cancer tissue and 1.0 and 1.1 for healthy breast tissue.
Therefore, all tissue samples with these values smaller than 1 can be considered
to be cancer tissue.
Since the differences between the spectra have to be found individually for
every specific application, a more general approach had to be found. Another
approach for the development of a new method was the fact that optical mul-
tichannel spectra (about 600 channels) cannot be obtained with the required
quality in the required time due to low light intensities in each channel. The
solution to this problem is a system with a reduced number of detectors. This
has two main advantages: First, we do not have to spread the small amount
of available photons over hundreds of detectors, which gives us better detection
statistics. Second, discrete high-sensitive devices (like photomultiplier tubes) in-
stead of CCD devices, which have lower sensitivity/quantum efficiencies can be
used.
The goal was to classify the tissues with a reduced number of channels in the
detection system. For a working model the following assumptions were made:
• The system contains just a given number of reference tissues. Every ob-
served point can be presented as a combination of these reference tissues.
• For mathematical simplicity, the same number of references and detectors
is used. Otherwise the system of equations would be under- or overdeter-
mined.
• The reference tissues have distinguishable spectral patterns. The reference
vectors are independent.
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In the analytic model for analysis described here, it is assumed that there are
only three types of tissue at any area of interest. Thus, each observed focal point
~e can be described as a combination of these three references:
~e = x1~a+ x2~b+ x3~c (5.1)
or
~e = A~x. (5.2)
The results described below were collected with a system of three detectors.
Therefore the analysis will be explained for the 3-dimensional case, i.e. there are
three detectors and three different reference tissues. For each point in the speci-
men three values are obtained, representing a vector in the space of possible sets
of values. Each value represents the autofluorescence intensity in a certain range
of the spectrum at the observed point of the specimen. For an analytic device in
stereotactic laser neurosurgery, a larger number of detectors (dimensions) should
be taken into account, which would increase the complexity of the system.
Figure 5.2: The analysis (OCSA-Transformation) of the spectra leads to a func-
tional picture.
In the first step, the device needs to be calibrated with three tissue samples
(references). The vectors ~a, ~b, ~c, representing the spectral intensities in the
three detection wavelength bands, are recorded and transferred to a 3x3 matrix
A. The matrix contains the three spectral ’fingerprints’ of the three references
(tissue samples):
~a,~b,~c⇒ A =

a1 b1 c1
a2 b2 c2
a3 b3 c3
 . (5.3)
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Calibration has to be done carefully, since the more exact the spectral finger-
prints of the reference tissues are taken, the more precise the classification of the
observed tissue will be. Usually an averaged spectral fingerprint of a certain area
of the reference sample is taken. During the surgical process it is necessary to
know which fractions (x1, x2, x3) of the three reference tissue types are present in
the observed volume of the tissue sample. As there is no relevant information in
the absolute intensity of the signal, all obtained vectors are ’normalized’: Each
value of the vector is divided by the sum of the three values of the vector.
The intensity of the signal is mainly influenced by the light-transmittance of
the material between the observed point and the optics or by slight out-of-focus
influences. Therefore, this information is not used for the given problem. In con-
trast, the relative intensities of the wavelength bands are mainly influenced by the
biochemistry of the cell and are therefore dependent on the type and the status of
the observed tissue. Vector ~x contains the entire information about the composi-
tion of the sample volume. To obtain this vector, the inverse matrix of A is used.
This inversion has to be done just once at the end of the calibration process.
During the rest of the measurement the three values received from the PMTs
have to be multiplied with the inverse matrix A−1 (OCSA-Transformation):
~x = A−1~e. (5.4)
Vector ~x represents the fraction of reference tissues in the sample volume.
If ~x can be clearly associated with one type of tissue, the pixel in the image is
color coded, corresponding to the type of tissue (Fig.5.2). A functional picture
is obtained. This information is submitted to the surgical system, which decides
what do do with the sample volume (coagulation, ablation, no action).
5.2 Experimental setup
In stereotactic neurosurgery tissue samples are observed by a conventional con-
focal laser scanning microscope, which is integrated in the probe [37]. A confocal
setup has to be used in order to suppress signals from beyond the observed point
of tissue (chapter 4.3). The OCSA serves as a point detector in the confocal
microscope.
For our experiments a tabletop setup is used (Fig.5.3). The laser is a HeCd
laser (IK 5652R-G, Kimmon electric co., ltd, Tokyo, Japan), which delivers
100 mW at the used wavelength of 442 nm. The beam splitter BS1 (344132:
20x30 mm2, BK7, R=10 %, T=90 %, Linos Photonics GmbH, Go¨ttingen, Ger-
many) is used to lower intensity; it divides the beam into two parts. The reflected
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Figure 5.3: Experimental setup with OligoChannel Spectrum Analyzer (OCSA)
for tissue detection: A HeCd-Laser is used as a light source. The first beam
splitter (BS1, reflectivity: 10%, transmission: 90%) reduces the intensity of the
emitted beam, lens 1 (L1), pinhole 1 (PH1) and lens 2 (L2) serve as a beam
expander and a spatial filter to maintain high beam quality. This part of the
setup is the point source in the confocal setup. Beam splitter 2 (BS2, reflectivity:
10%, transmission: 90%) reflects 10% of the light onto the objective lens (O),
which focuses the light onto the sample on the translation stage (TS). 90% of the
light emitted by the probe and collected by the objective lens are transmitted
through beam splitter 2 (BS2) onto the detection system. The dicroic beam
splitter (BS3) separates the light into the excitation wavelength and the rest of the
spectrum. The excitation wavelength is reflected onto a point detector consisting
of of L6 (focusing lens), PH3 pinhole, and a photomultiplier tube (PMT). The
transmitted spectrum is analyzed in the OCSA, which is also a point detector:
The light is focused onto the pinhole 2 (PH2). Therefore the OCSA serves as a
point detector in the confocal setup. Lens 4 (L4) forms a parallel beam, prism
(P) refracts the light dependent on the wavelength into different directions. Lens
5 (L5) refocuses the light onto a detector array (PMTA). A spectrum with only
a few channels is collected.
10 % (real: 17 mW ) are used for our experiments, 90 % of the intensity are
transmitted and rejected. The rejected part of the beam could be used for other
experiments (see discussion). The beam is expanded to a diameter of 8 mm by
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two standard microscope lenses L1 (04 OAS 016: 40x0.65, Melles Griot, Irvine,
USA), L2 (04 OAS 006: 4x0.12, Melles Griot, Irvine, USA) and a pinhole (di-
ameter 20 µm). Behind the beam expander the intensity has dropped to 4 mW .
The actual beam splitter for the confocal setup is beam splitter BS2 (344132:
20x30 mm2, BK7, R=10 %, T=90 %, Linos Photonics GmbH, Go¨ttingen, Ger-
many). The use of this beam splitter has the advantage, that most (90 %) of the
light emitted by the probe in the acceptance angle of the objective O (04 OAS
010: 10x0.25, Melles Griot, Irvine, USA) is transmitted to the detection unit.
A light intensity of 10 % (0.65 mW on the sample) was shown to be sufficient
for this setup in our experiments. As we wanted to examine tissue in vivo, the
exposure should be kept as low as possible. The translation stage (TS) consists
of a x-y-z stage for rough positioning of the probe and, mounted onto this, a
piezoelectric stage (PXY 400, Piezosysteme Jena GmbH, Jena, Germany; control
electronics: MRC-Systems GmbH, Heidelberg, Germany) for x-y scanning with a
range of 400 µm. In the laboratory experiments, object scanning instead of beam
scanning was is for simplicity. The tissue sample is mounted onto the piezoelec-
tric actuator and fixed between two cover slips. The dicroic beam splitter BS3
(glass plate with custom coating dlhs 308, Melles Griot, Irvine, USA) divides the
light, which is emitted by the sample volume into the excitation wavelength of
the laser and the rest of the spectrum. The transmitted part of the spectrum
is analyzed by the OCSA: The light is focused by L3 (04 OAS 010: 10x0.25,
Melles Griot, Irvine, USA) through the pinhole PH2 (diameter 25 µm), thus
the OCSA (Fig.5.3:OCSA) can be considered as a point detector in the confocal
setup. A picture of the laboratory setup is shown in Fig.5.4. The light crossing
the pinhole PH2 is formed into a parallel beam by lens L4 (04 OAS 006: 4x0.12,
Melles Griot, Irvine, USA). The prism P (336672, SF10, 30 mm x 30 mm, Linos
Photonics GmbH, Go¨ttingen, Germany) deflects the light into different directions
(dispersion) dependent on the wavelength; Lens L5 (063215, f=120 mm, Linos
Photonics GmbH, Go¨ttingen, Germany) refocuses the beam onto a detector ar-
ray PMTA (three H 5784, Hamamatsu Photonics K.K., Shizuoka-ken, Japan).
The three detectors cover the spectral ranges as follows: detector one 450-500
nm, detector two 500-550 nm, detector three 550-600 nm. The complete OCSA-
setup is mounted in a light-tight box system (Fig.5.6) with light-tight electrical
connection board (Fig.5.7).
A limited number of photomultiplier tubes (PMTs) is used for detection due
to their high sensitivity and speed. These photosensor modules contain a built-
in amplifier which limits the bandwidth to 20 kHz. The control and supply
electronics was built by the electronics workshop of the Kirchhoff Institute of
Physics Heidelberg. It fulfils the 4 kHz requirement of the stereotactic laser
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neurosurgery application. By using several detectors, much more information is
obtained from the specimen compared to just looking at the overall intensity.
The values delivered by the detector array ware digitized by a Data AcQuisition
(DAQ) card (PCI-MIO-16E-1, National Instruments, Austin, USA) in a personal
computer and analyzed as described in section 5.1.
Figure 5.4: Overview of the OCSA. The light to be analyzed is focused by
lens (L3) onto the pinhole (PH2). The light enters the light-tight box (Fig.5.6)
through the pinhole and is collimated by lens (L4). The prism (P) spreads the
light, which is refocused by a lens (L5) onto the micro-mirror (M). The micro-
mirror distributes the light over the detectors (PMT). The micro-mirror and the
PMTs form the detector array (Fig.5.3:PMTA).
As we wanted to use discrete photo multiplier tubes (PMTs), the light had
to be distributed among the PMTs. The actual hole for incoming light in the
housing of a PMT is quite small compared to the size of the whole sheath. Thus,
by spreading the spectrum over this array, part of the light would hit the housing
and not the light sensitive opening window, if the tubes were arranged close to
each other. Since in our experiments no waste of light can be accepted due to
the fact that very low light levels are available, the following setup was used:
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Figure 5.5: Detailed views of the micro-mirror PMT setup.
Figure 5.6: The light-tight housing for the OCSA consists of elements for the
edges and pieces for the wall inserted between two of the edge elements.
The light entering the detection unit through the detection pinhole (PH2) is
collimated by a lens (L4) into a parallel beam. This parallel beam is crossing a
prism (P). Dependent on the wavelength of the photons, an angular dispersion is
added to the wavelength. This beam with the imprinted wavelength-dependent
dispersion is refocused by a lens (L5). The lens does not refocus the beam to a
focus spot, because the color dispersion of the prism results in expansion of the
focal spot to a focal line. The wavelength with angular divergence is refocused off
the optical axis of the lens. In this focal line, a micro-mirror (M) with four facets
is installed. Dependent on the wavelength the light is reflected into four different
directions. No light is wasted, because the filling-factor of the micro-mirror is
close 100 %.
As there was no suitable commercial mirror available and the glass workshop
of the university was not able to cut such mirrors without destroying the reflective
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Figure 5.7: The electrical signals have to be conducted by a light-tight connection
board integrated into the light-tight housing for the OCSA. left: inner view; right:
outer view.
Figure 5.8: left: Close up of the micro-mirror (four facet version) array built for
the experiments. right: Schematic drawing of the micro-mirror; the reflecting
surfaces (planes) of the mirror facets intersect in a line (black line).
surface, A device had to build in order to cut the mirrors. The device consists of
a rapidly rotating miniature cutting disk and a translation table. The translation
table is driven by a stepping motor, enabling a precise an extremely slow move-
ment (5 mm per hour) of the glass. The piece of mirror is clamped in a small
vice on the translation stage. Small stripes, 1 mm to 2 mm in height and about
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7 mm in length were cut from a mirror. Due to the slow feed, the surface of the
reflective mirror remains unaffected. Four of these small mirror parts are glued
together in such a manner that the four planes of the mirrors intersect in one line
(Fig.5.8). The light divided by the prism is refocused exactly onto this line. The
height of the mirror elements lays down the size of the wavelength band picked by
one mirror element. In the experiments described, mirror elements with a height
of 1.9 mm were chosen. With the used prism and the 120 mm refocusing lens
this results in wavelength bands of 50 nm (see chapter 4.1). In our experiments
the device was calibrated in order to pick three bands (450-500 nm, 500-550 nm,
550-600 nm).
5.3 Software implementation
The whole system is controlled by a C++ program [62, 63]. A graphical user
interface (GUI) based on the QT library eases the application of the OCSA sys-
tem. The QT environment offers a palette of components required to create
a user interface, like buttons, sub-windows, frames, sliders, text windows, etc.
Platform-independent and object-oriented design assures easy expansion and in-
tegration into the stereotactic neurosurgical environment used for planning and
control. With in the QT toolkit a ’signal-slot concept’ is available for handling
of actions triggered by other actions, like pressing a button. Any part of the pro-
gram can send a signal. The signal is received by an other part of the program
to read out a status and start an action. In the OCSA program, the signal-slot
concept is used for all the buttons on the graphical user interface.
In the main application window different functions are available.
• Single: A single image is obtained with high quality (mean of 1000 mea-
surements).
• Continuous: This starts a continuous imaging process.
• FastScan: An image is taken with high speed.
• Stop: The actual measurement is stopped.
• Config: This button opens the configuration window, which is used for
calibration of the system.
The ’Single’-scan button starts the acquisition of a single image of high qual-
ity. Every point of the sample is measured 1000 times in order to minimize the
impairment due to statistical fluctuations in the data. This mode is generally used
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Figure 5.9: Screen shot of the graphical user interface of the implemented pro-
gram.
for demonstrations, i.e. for obtaining single images of high visual quality. As one
has to deal with relatively low light intensities, nicer images can be obtained in
this way. As a second effect, this mode slows down the piezoelectric x-y-scanner,
which leads to a better image quality, because image distortions due to limita-
tions of the piezoelectric translation stage are reduced. Recording of a 256 by
256 pixel image takes about 10 minutes in this mode. In the real neurosurgery
setup, beam scanning is used. This means that the beam is moved relative to the
probe. In the used setup, the sample is moved relative to a spatially fixed beam.
While scanning the sample, acceleration has to be small, otherwise the sample
(biological material has no rigid structure) would move relative to the translation
stage. However, much faster scanning (e.g. with beam scanning) with at least
the required 4 kHz point frequency is theoretically possible.
The ’Continuous’ and ’FastScan’ buttons are used for measurement. The
’Continuous’ scanning mode is used to look for a proper section on the sample. It
is also applied to adjust the sensitivity of the PMTs. This sensitivity adjustment
can be automated in future implementations, but the actual power supply and
control electronics do not provide an external input for the control voltage. The
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high voltage (kV ) of the PMTs is controlled by a control voltage (0-1 V ). In
future setup, this voltage may be supplied by an output card in the computer,
enabling an automated determination of the best working point for a given light
level.
With the ’Stop’ Button the present action is terminated.
On the screen, there are two fields displaying four images each. The left
four images are reserved for the intensity images obtained by the detectors. No
image processing is used at this point. The vector, which is calculated from the
values measured by the detectors is divided by the sum of these three values
of the vector. The right four images display the analyzed data. Each channel
represents the contribution of the corresponding reference tissues in the sample.
Since all examples show a three-detector system, the fourth images are empty
(Fig.5.9).
Pushing the ’Config’ button opens a new window. The ConfigDialog window
contains the tools required for calibration of the system (Fig.5.10). When the
’Reference’ buttons (1-3) are pushed, a reference measurement is performed. The
values are written into a matrix. The inverse matrix is calculated when the
’Inverse Matrix’ button is pressed. This matrix is used in the main window for
analysis.
Figure 5.10: Screen shot of the configuration window for system calibration.
At the bottom of the main window of the ’OligoChannel Spectrum Analyzer’
program there are several status displays (Fig.5.9). An array of nine text fields
displays information about the actual scan line and the actual values (measured
and OCSA-calculated) of the measured point. In addition, there is a multi-line
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status field to display the actual status of the system (single picture in progress,
single picture done, single picture cancelled, etc.). A bar graph shows the actual
progress of action.
Chapter 6
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6.1 Preparation of the tissue samples
6.1.1 Mouse tissue
In order to get as close as possible to in vivo conditions fresh tissue samples were
used.
The goal in the preparation of the sample was to keep as much of the origi-
nal in vivo-properties of the tissue observed in vitro. Therefore no conservation
techniques were applied. Even no cooling was used in order to avoid changes in
the properties of the tissue. Due to the relatively long measurement duration,
only the first experiments with a set of tissue samples were really close to in vivo
conditions.
Figure 6.1: The mouse tissue samples.
The first experiments were done with mouse tissue received from the exper-
imental animal lab of the German Cancer Research Center (DKFZ, Heidelberg,
Germany). The mouse was killed and the tissue samples were extracted immedi-
ately. Brain, heart, lung, kidney, and liver tissue were obtained (Fig.6.1).
The samples were prepared for the experimental setup in about ten minutes.
No conservation techniques were used in order to maintain as many in vivo-
properties of the tissue as possible. For each specific experiment, pieces of three
of the tissue samples were arranged inside a small chamber between two cover
slips in a custom made mount (Fig.6.2).
Each piece of tissue was of the size of about 5 mm3. The mount was then fit
to the piezoelectric translation stage (Fig.6.3). The experiments itself took about
half an hour each, i.e. measurements were conducted over a period of 30 min.
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Figure 6.2: The sample mount. left: open mount with tissue samples; right: front
view of the assembled mount.
Figure 6.3: The tissue chamber mounted to the translation stage/piezoelectric
scanner.
6.1.2 Human tissue
The human tissue samples were obtained from the pathology department of the
German Cancer Research Center (DKFZ, Heidelberg, Germany). The specimen
had been taken from a 53 year old woman, who had undergone resection of
cancerous kidney tissue. In addition to the cancerous tissue a small piece of
healthy tissue was obtained for comparison. This piece of healthy tissue contained
a very small inclusion of fat tissue, which was used as the third tissue type for
the experiments. The human tissue was processed in the same way as the mouse
tissue.
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6.2 Experimental results
Preliminary tests with the OCSA setup were conducted with pig tissue obtained
from a local butcher’s shop. All shown images have a size of 400 µm by 400 µm.
Figure 6.4: Autofluorescence signal of tissue samples obtained from the local
butcher’s shop. Measurements with the three photomultiplier tubes, of which
signals are shown separately (left: 450-500 nm; center: 500-550 nm; right: 550-
600 nm). The excitation wavelength is 442 nm.
Figure 6.5: Images in the domain of the reference tissues after analysis with the
OCSA-Transformation. Channel one (left) corresponds to fat tissue, channel two
(center) to liver tissue and the third channel (right) represents muscle tissue.
The images in Fig.6.4 show the measured intensities, collected by the three
PMTs. Fig.6.5 shows the area after analysis (in real time) with the OCSA.
All three channels, corresponding to the three reference tissues, show a signal,
since the intersection of all three tissues was imaged. Fig.6.6 shows a composed
image of Fig.6.5. Each color corresponds to one of the reference tissues. Red
corresponds to fat tissue, green to liver tissue and blue to muscle tissue. As
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Figure 6.6: The images of Fig.6.5 are composed to a color coded image. Red
corresponds to fat tissue, green to liver tissue and blue to muscle tissue.
these tests showed very promising results, further experiments closer to in vivo
conditions were conducted.
6.2.1 Mouse tissue
The following experiments were done with a set of mouse tissues (brain, heart,
kidney, liver, lung). For each experiment three of these tissues were combined on
a coverslip as described in chapter 6.1. The system was calibrated as described
above and subsequently transitions between two of the three tissues were imaged.
Fig.6.7 nicely illustrates the conducted experiments. Three of the mouse
tissues were combined in one sample. Their geometry is shown in Fig.6.7(upper
left). Three detailed images at three different transitions between the tissues were
made (Fig.6.7: M1, M2, M3). This example shows that a distinction between
three tissues is possible with the used setup.
The following results presented were conducted with white brain matter, grey
brain matter and liver tissue, in order to demonstrate that the method works in
brain applications as well.
Fig.6.8 and 6.9 show the transition from grey to white brain matter. Fig.6.8
shows the measured signals from the PMTs, whereas Fig.6.9 shows the images
after analysis of the data with the OCSA (achieved in real time). The three
channels are shown separately. Channel one corresponds to white brain matter,
channel two to grey brain matter and the third channel to liver. After analysis
with the OCSA clear signals were obtained from channel one and two, whereas
channel three, which corresponds to reference tissue liver (not contained in the
displayed part of the specimen) showed nearly no signal. Thus, the specificity of
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Figure 6.7: Upper left: schematic drawing of the arrangement of the tissues in
the mount. M1, M2, M3: detailed images obtained with the OCSA.
Figure 6.8: Autofluorescence signal of mouse tissue (white and grey brain matter)
measured by the three photomultiplier tubes which are shown separately (left:
450-500 nm; center: 500-550 nm; right: 550-600 nm). The excitation wavelength
is 442 nm. Very low contrast is visible when no image enhancements are applied.
the method was nicely illustrated. In Fig.6.10 the three channels were combined
to a single color-coded image. Red corresponds to white brain matter, green to
grey brain matter and blue corresponds to liver tissue.
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Figure 6.9: Images in the domain of the reference tissues (Fig.6.8 after analysis
with the OCSA). Channel one (left) corresponds to white, channel two (center)
to grey brain matter. The third channel (right) represents liver tissue, which
is not present in the imaged part of the sample and therefore shows nearly no
signal.
Figure 6.10: Combined image in the domain of the reference tissues. The channels
shown in Fig.6.9 are combined to a color image. Red corresponds to white brain
matter, green to grey brain matter and the blue color corresponds to liver tissue
(not existent in the imaged region of the smple).
Each tissue sample in these triplets (any given combination of three of the
mouse tissues) could be clearly determined after the calibration of the system. In
Fig.6.11(left), the histogram of channel two (Fig.6.9(center)) is displayed. This
histogram clearly shows that most of the pixels are zero (corresponding to white
brain matter) or 256 (corresponding to grey brain matter). No special optimiza-
tion is done at this point, despite the ’normalization’ mentioned above (in 5.1).
Fig.6.11(right) shows the intensity of channel two after analysis with OCSA
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Figure 6.11: Transition from grey to white brain matter. left: histogram of
Fig.6.9(center). Most of the pixels are associated with zero (in this case corre-
sponding to white brain matter) or 256 (corresponding to grey brain matter);
right: the transition is fitted with a sigmoidal curve. The intensity at the tran-
sition from grey to white brain matter falls from 90 % to 10 % along about 25
µm, indicating that the transition is detected with an accuracy of 25 µm.
along a line crossing the transition perpendicular to the borderline between grey
and white brain matter. The sigmoidal curve fit to the data can be used to
obtain the spatial resolution of the fluorescence microscope. The intensity at the
transition from grey to white brain matter falls from 90 % to 10 % across about
25 µm, indicating that detection accuracy of a transition is 25 µm.
6.2.2 Human kidney tissue
After this successful approach with mouse tissues, further experiments were done
using human tissue from a 53 year old woman, who had undergone resection of
a carcinoma in the kidney. Three types of tissue were used: kidney carcinoma,
healthy kidney tissue, and fat tissue.
The images in Fig.6.12 show the autofluorescence intensities measured by the
three photomultiplier tubes without application of the OCSA-Transformation
(equation 5.4). Nearly no contrast is visible in these pictures. However, Fig.6.14
nicely shows that after analysis with the OCSA (but no additional image process-
ing, despite the ’normalization’ mentioned above (in chapter 5.1)) the same im-
ages show much more contrast (Fig.6.13). Channel three (Fig.6.13(right)) shows
a very low signal, thus illustrating that there is almost no reference tissue three
(fat) present in the observed specimen, whereas the signals of channel one (carci-
noma, Fig.6.13(left)) and channel two (healthy kidney, Fig.6.13(center)) can be
clearly distinguished.
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Figure 6.12: Autofluorescence signal of human tissue (transition between kidney
and kidney carcinoma) measured by the three photomultiplier tubes which are
shown separately (left: 450-500 nm; center: 500-550 nm; right: 550-600 nm).
The excitation wavelength is 442 nm. Nearly no contrast is seen without any
image enhancement.
Figure 6.13: Images in the domain of the reference tissues (Fig.6.8 after analysis
with the OCSA). Channel one (left) corresponds to carcinoma of the kidney
and channel two (center) to healthy kidney tissue. The third channel (right)
corresponds to fat tissue. These images show strong contrast, although there is
nearly no contrast seen in the images taken without the OCSA-Transformation.
Most of the values are associated with healthy kidney tissue (value: 256),
which corresponds to the real distribution in the sample.
So far only basic operations were applied to the obtained data: Two opera-
tions were applied to all vectors (measurement and calculation). First, all values
smaller than zero were set to zero, in order to suppress errors of the PMT’s
amplifiers. In the second step, each vector value (corresponding to one point
in the sample) was divided by the sum of the values of the vector. This op-
eration was done in order to suppress the effect of intensity fluctuations of the
measured results (Only the relative intensities are of interest). Strikingly, even
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Figure 6.14: The images of Fig.6.13 are combined to a color coded image. Red
corresponds to carcinoma, green to healthy kidney tissue and blue to fat tissue.
Figure 6.15: Histogram of the left half of Fig.6.13(center). Most of the pixels are
either zero (in this case corresponding to carcinoma) or 256 (corresponding to
healthy kidney).
with this simple method, very good results were obtained (see above). No image
enhancement at all was applied to the images shown.
In the experiments described above it was possible to distinguish tissues in
any given set of tissue triplets. Fig.6.15 shows a histogram of the left half of
channel two (Fig.6.13(center)). This histogram shows, that most of the pixels
were either zero (in this case corresponding to carcinoma) or 256 (corresponding
to healthy kidney). No special optimization was done at this point, which could
further increase image quality.
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7.1 Discussion
Stereotactic laser neurosurgery is a recently developed method for resection of
tumors from human brains. While conventional radiotherapy destroys relatively
large areas of healthy brain tissue surrounding a tumor, stereotactic laser neu-
rosurgery allows precise ablation of cancerous tissue without X-ray irradiation.
However, the practical application of this method is at present associated with
several problems and impediments. Thus, improvement of stereotactic laser neu-
rosurgery is necessary because of the following reasons:
The precise delimitation of cancerous and healthy tissue is of high importance
in order to prevent resection of healthy brain tissue. At present, the standard
monitoring methods prior to and during an operation are CT and MR imaging
methods, which show rather poor resolution. Additionally, these methods only
deliver overall images from rather large brain sections but no detailed analysis
of the actual point of interest during an operation. Thus, precise detection of
various critical tissue types, e.g. blood vessels inside the brain is difficult when
CT and MRI data are used as the only source of information. Real time imaging
with CT and MRI is difficult due to the poor time resolution of these methods.
The aim of this work was planning, experimental design and application of a
new analytic device which solves the above mentioned problems. One possibility
to improve the reliability of detection of cancerous tissue in the brain is the
use of fluorescent dyes. Several exogenous fluorescent dyes which were shown
to specifically stain tumor tissue are known. However, their application is quite
risky, as described in chapter 3.1. Since such fluorescent dyes specifically stain
tumors, they do not allow mapping of other structures like blood vessels.
In contrast, this work was based on the idea of making use of the autoflu-
orescence properties of cells. As described in chapter 3.3, it was shown before
that it is possible to visualize and identify different types of tissues by analyzing
their autofluorescence spectra. Many examples for cancer detection by fluores-
cent light, using the intrinsic autofluorescence properties of tissues, are given in
literature [43, 68].
In order to make use of the relatively low autofluorescence intensities of tissues
in the brain and to ensure the reliability of detection, a new and very sensitive
analytic device, the OligoChannel Spectrum Analyzer (OCSA) was developed,
realized for experimental applications and tested. With the OCSA, an analytic
device with a more general approach was developed. Unlike in other methods it
is less important to figure out an optimized combination of excitation and detec-
tion wavelengths with the OCSA, because the analysis of spectra is done by the
multiplication with a matrix (OCSA-Transformation) obtained in the calibration
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process. This matrix itself is extracted from the spectral fingerprints of reference
tissues and therefore includes all required information about the working config-
uration. During the process of calibration, three points in the brain are accessed.
One point is chosen in healthy tissue on the path to the tumor, identified as
healthy with the CT and MRI data. As a second point, a blood vessel is chosen.
Finally, the third reference tissue measurement is taken inside the tumor volume
before ablation starts. With these spectral fingerprints all information required
for analysis is available.
Unfortunately, the natural fluorescence of cells, especially of brain tissue, is
very low. Therefore, very long exposure times are necessary for detection with
conventional OMAs. Such long exposure times are not tolerable in stereotactic
brain surgery, since every point needs to be analyzed before ablation. Ablation
of each point is done with a repetition rate of 4 kHz. This frequency cannot
be reduced, since this would extend the duration of a surgery to a unacceptable
length. OCSA meets the 4 kHz requirement due to its real time capability.
Our preliminary results nicely illustrate that it is possible to distinguish dif-
ferent types of tissue by examination with the OCSA (proof of principle). Each
of the tissue triplets that were tested could be analyzed and the tissues could
be classified with high reliability. Images obtained from autofluorescence mea-
surements in mouse and human tissues provide information about the different
fractions of reference tissues at any observed point of the specimen. Therefore,
this new technique may provide an immediate light-biopsy diagnosis of cancer in
vivo.
The goal of tissue sample preparation for our experiments was to keep as
much of the in vivo properties of the tissue during measurements. Therefore, no
conservation techniques were applied at all. In order to avoid changes of tissue
properties, even cooling was avoided. It should be noted that, due to the relatively
long durations of measurement, tissue properties might have changed during and
between each measurement series. In the next step in vivo experiments could
demonstrate the applicability of the method under real stereotactic conditions.
In this context it is important to note that the dimensions of the apparatus, at
least the part which is inserted into the patient´s head, do not increase when the
OCSA is used. Thus, the use of the OCSA would not bring any disadvantages to
the patient in terms of seriousness of an operation.
No additional optimization was done, like searching for suitable wavelengths.
Both, excitation (442 nm) and detection (450-500-550 nm) wavelengths were
fixed.
For optimization of the results, examination and detection wavelengths could
be chosen individually for any given application. For example, good results were
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reported using laser light in the UV for applications in the brain [69]. But with
the used setup (excitation 442 nm, detection 450-500-550 nm), a clear distinction
between white and grey mouse brain matter was possible, indicating applicability
of the used setup for stereotactic laser neurosurgery. Another possible enhance-
ment may result from the use of a larger number of channels/detectors, as there
are more than just three types of tissues present in the human brain. By using
more than three channels a refined detection might be possible. Two or more
channels can be associated with slightly different kinds of one type of tissue,
allowing a tolerance in the detection.
The data can be analyzed and checked for plausibility, e.g. by matching
adjacent pixels. It has to be evaluated whether there are parameters which allow
a general use without the calibration process prior to each surgery.
The spatial resolution of the used setup is in the range of the ablated vol-
umes and thus sufficient for the diagnosis of cancerous tissue during stereotactic
neurosurgery. In a stereotactic laser neurosurgery setup the resolution is fixed by
the properties of the lens in the periscopic probe tip. Since this lens is used for
focusing the high energy laser beams as well as an imaging lens in the confocal
setup, the resolution of detection is in the same range as the size of the ablated
sample volume. This is sufficient in terms of analysis of the next sample volume
of interest. Actually, the resolution is even better than that, since a confocal
setup has an improved resolution (factor 1.4) compared to a conventional setup:
the focused high energy laser beam can be seen as the illumination spot of a
conventional scanning microscope (Fig.4.5(c)).
In addition, the laser used for diagnosis has a better beam quality (at least
after spatial filtering in the beam expander) than the high energy lasers, leading to
a smaller spot size and therefore higher resolution. The detection of fluorescent
dyes in stereotactic neurosurgery, via a confocal microscope integrated in the
optical probe, was evaluated by Zenzinger et al. [37]. In vitro experiments with
the actual optical setup were performed [33].
The spatial resolution mainly depends on the optical setup of the confocal
microscope in which the OCSA is used as a point detector. Therefore it can be
easily adapted to a given problem (desired resolution) by changing the optical
setup of the confocal microscope, including the detection/entrance pinhole of the
OCSA.
Ensuring precise detection is necessary in order to make use of the precise
plasma-induced ablation. However, it might be an advantage to induce thermal
damage to parts of the tissue in order to stimulate the immune system to work
against some possible residual tumor tissue and metastases. It is reported that
after thermal treatment of a tumor, remaining tumor tissue and even metastases
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are eliminated by the immune system. Therefore, this additional stimulus, e.g.
by heat induced damages induced with the coagulation system, might be useful
to completely eliminate the cancer.
During an operation, the results received with the OCSA can be used for
precise navigation, whereas the images obtained from CT/MRI (resolution in the
mm-range) may be used for rough navigation. As the geometry in the human
skull changes due to displacements of the brain when tumor volume is ablated,
the online control with OCSA (in addition to the online MRI control, during the
surgery an open MRI device can be used to improve access to the patient’s skull)
increases the precision of the tumor resection significantly.
The excitation wavelength reflected by the beam splitter BS3 (Fig.5.3) can
be analyzed by a point detector in order to obtain pictures in the reflection mode
(not used in the experiments described in this work). This may provide additional
imaging information. The value of this information has to be evaluated for a given
application.
To fulfil the need of MR compatibility, a fiber optic laser scanning microscope
can be used. The fiber serves as a point source and point detector in the setup
[70]. A main advantage of this would be that the detectors could be placed away
from the high B-field of the MRI device
7.2 Conclusion
With the new OCSA direct information about the constituents of the observed
tissue is obtained by analyzing its autofluorescence spectrum. With the use of just
a few channels it is possible to acquire data with high sensitivity and speed. All
data are sent to the computer simultaneously. The only general limitations are the
read-out speed of the PMTs and the number of emitted photons. By using more
than just the overall fluorescence intensity additional information is obtained. By
transforming data with the new OCSA-method (OCSA-Transformation) tissue
types can be identified. With this information the ablation process is controlled
in order to remove cancerous tissue selectively and with high precision.
As there are some optimization possibilities available (larger amount of chan-
nels, better detectors, specialized setup for a given application, matching of ad-
jacent points for plausibility check, etc.), there should exist a working setup of
the OCSA for any given application.
Additionally, there might be various possible application areas in diagnostics.
For every application, with three or more channels, like e.g. a confocal scan-
ning microscope, this algorithm (OCSA-Transformation) can be implemented to
CHAPTER 7. DISCUSSION AND CONCLUSION 74
receive additional information about the observed object.
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Adaptive Optics (AO) is used to correct optical aberrations in an optical
system induced by changes in the refractive properties of optical elements. It is
a widely used technique in astronomy. Imperfect optical elements are e.g. the
atmosphere in case of astronomy, or in case of stereotactic neurosurgery, the
biological sample and the irrigation liquid which have to be passed by the beam
in order to get to the imaged part of the sample.
As in confocal microscopes the samples are imaged point by point, there
is no need to correct several planes in order to correct all aberrations like in
astronomy. In astronomy, the wavefront is sensed by using a bright star or a
laser beacon (laser guide star). The correction is valid for the area around the
beacon and in a specific layer in the atmosphere only. The corrective element is
in a corresponding layer to a layer in the atmosphere. Only the turbulences in
this layer are completely corrected. For a better correction, a multilayer adaptive
optic system has to be used. A transition to many layers leads to a tomographic
access. That means that the turbulences in the whole passed atmospheric space
are measured and corrected. The consequence is an immense increase in system
complexity.
A.1 Adaptive Optics in Stereotactic Laser Neu-
rosurgery
In Fig.A.1 a system overview of an AO stereotactic laser neurosurgery setup is
given. One part is the spectrometer and OCSA section analyzing the observed
point and controlling the lasers for ablation and coagulation.
The second control loop in this setup is the AO system. It consists of a
Hartmann-Shack Sensor (HSS) analyzing the wavefront and an actuator correct-
ing the aberrated wavefront. The analysis of the data delivered by the HSS and
the control of the actuator is done with a regular computer. The system has
to work in real time. At the moment the used HSS (with ASIC detector, see
chapter A.2.1) and mirror (membrane mirror, see chapter A.3) are limited to a
frequency of about 500 Hz. Further research is necessary to meet the 4 kHz
requirement for the use in stereotactic laser neurosurgery. The position of the
actuator (corrective element) is chosen in order to correct the distortion of the
microscope signal and to pre-correct the high energy laser beams.
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Figure A.1: System overview of an adaptive confocal fluorescence microscope
for stereotactic neurosurgery. [71]. (BS: beam splitter, HSS: Hartmann-Shack
sensor).
A.2 Wavefront sensing
The propagation of light can be described with wavefronts, which are planes of
equal phase. These wavefronts are perpendicular to the rays used in geometric
optics. In this work only Hartmann-Shack sensors (HSS) in combination with a
membrane mirror are described in detail.
A.2.1 The Hartmann-Shack wavefront sensor
The wavefront can be measured with a Hartmann-Shack wavefront sensor (HSS).
Its basic principle was invented by Hartmann for quality testing of telescopes. In
the first setup, a parallel beam was incident on an array of pinholes. The tested
lens behind the pinhole-array focused the light. In two planes before and behind
the focal plane images were taken. With an ideal lens corresponding points on
the two images are in corresponding positions. With an imperfect lens, the points
are displaced and the aberrations can be analyzed.
In 1971, Shack refined this principle by replacing the pinhole-plate by an array
of small lenses. Each lens samples a small part of the wavefront. The displacement
of a focal point of one lens represents the averaged tilt of the wavefront in the
area of the lens. Parallel light with a small angle of incidence to a lens is focused
onto the focal plane, but with a displacement from the optical axis (Fig.A.2 left).
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Figure A.2: left: Displacement of the focal point of a lens. right: Hartmann-
Shack sensor.
The displacement is:
∆x = f × tanα (A.1)
A Hartmann-Shack sensor (HSS) consists of a microlens-array and a CCD
device for imaging. The image on the CCD-device is digitized by a frame-grabber
in a computer and analyzed.
For real time applications, the use of a CCD-device in combination with a
frame-grabber is often too slow. Therefore an Application Specific Integrated
Circuit (ASIC) is developed [72]. This microchip combines a detector array and
some of the analytic circuits. Detection rates in the kHz-range are possible.
A.2.2 Wavefront reconstruction
The slope of the wavefront is measured at several points with the HSS. At N
points, corresponding to the centers of the lenses, the slope of the wavefront is
known. i gives the number of one element (lens).
∂W (xi, yi)
∂x
=
∆xi
f
(A.2)
∂W (xi, yi)
∂y
=
∆yi
f
(A.3)
This equation can be solved with a wavefront built from orthogonal polyno-
mials Li. M is the maximal rank of the polynomials:
∂WT (x, y)
∂x
=
M∑
i=1
kiLi(x, y) (A.4)
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∂WT (x, y)
∂y
=
M∑
i=1
liLi(x, y) (A.5)
For the criterion of the fit the method of least square fit is used: The square
of the deviation S between the wavefront derivative and the measured derivative
for x and y has to be minimal:
S =
N∑
i=1
(∆xn
f
− ∂WT (xn, yn)
∂x
)2
+
(
∆yn
f
− ∂WT (xn, yn)
∂y
)2 (A.6)
With equation A.4 we get:
S =
N∑
i=1
(∆xn
f
−
M∑
i=1
kiLi(xn, yn)
)2
+
(
∆yn
f
−
M∑
i=1
liLi(xn, yn)
)2 (A.7)
The sum is minimal for:
0 =
∂S
∂kj
=
N∑
n=1
M∑
i=1
(
kiLi(xn, yn)− ∆xn
f
)
Lj(xn, yn) (A.8)
0 =
∂S
∂lj
=
N∑
n=1
M∑
i=1
(
liLi(xn, yn)− ∆yn
f
)
Lj(xn, yn) (A.9)
This can be transformed:
N∑
n=1
∆xn
f
Lj(xn, yn) =
M∑
i=1
ki
N∑
n=1
Li(xn, yn)Lj(xn, yn) (A.10)
N∑
n=1
∆yn
f
Lj(xn, yn) =
M∑
i=1
li
N∑
n=1
Li(xn, yn)Lj(xn, yn) (A.11)
For orthogonal polynomials (they have to be normalized for the given detector
geometry) with i 6= j:
N∑
n=1
Li(xn, yn)Lj(xn, yn) = 0, (A.12)
These can be solved to get ki and li
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ki =
∑N
n=1
∆xn
f
Lj(xn, yn)∑N
n=1 Li(xn, yn)
2
(A.13)
li =
∑N
n=1
∆yn
f
Lj(xn, yn)∑N
n=1 Li(xn, yn)
2
(A.14)
By comparison of the coefficients the so-called Zernike polynomials are ob-
tained.
A.2.3 Zernike polynomials
The polynomials were introduced by Zernike in 1934 to describe aberrations in
spherical mirrors. The polynomials are orthonormal over a circle with diameter
one. The polynomials represent classical aberrations. In table A.1 the first 15
polynomials (up to the fourth rank) are listed.
Rank mononom-notation name
0 Z0 1 constant
1 Z1 x x-tilt
Z2 y y-tilt
2 Z3 2xy astigmatism ±45◦
Z4 2x
2 + 2y2 − 1 defocus
Z5 y
2 − x2 astigmatism 0◦/90◦
3 Z6 3xy
2 − x3
Z7 −2x+ 3xy2 + 33 x-coma
Z8 −2y + 3x2y + 3y3 y-coma
Z9 y
3 − 3x2y
4 Z10 4y
3x− 4x3y
Z11 −6xy + 8y3x+ 8x3y
Z12 1− 6y2 − 6x2 + 6y4 + 12x2y2 + 6x4 spherical aberration
Z13 −3y2 + 3x2 + 4y4 − 4x4
Z14 y
4 − 6x2y2 + 4x4
Table A.1: Zernike-polynomials in the notation of Malacara.
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Figure A.3: Membrane mirror mount mounted onto a circuit board with connect-
ing cables.
Figure A.4: Schematic drawing of the structure of a membrane-mirror.
A.3 Membrane mirror
For the correction of the wavefront a membrane-mirror from Oko Technologies
(Netherlands) was used (Fig.A.3). 37 hexagonal electrodes are arranged under-
neath the membrane. Dependent on the voltages applied to the elements, the
form of the mirror is changed. Structure and setup of the mirror are schemati-
cally shown in Fig.A.4. Fig.A.5 shows the measured mirror surface with applied
voltages to element 1 (left) and to element 2 (right). The measurements are
obtained with an Twyman-Green interferometer (Fisba optic, Switzerland).
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Figure A.5: Interferometric images of the mirror surface. left: Voltage applied at
element 1. right: Voltage applied at element 2.
A.4 Curvature sensing
Roddier et al. described a method called curvature sensing for wavefront sensing
[73]. The wavefront is focused by a lens. By comparing two irradiance distribu-
tions at equally spaced points on either side of the focal plane, the local curvature
(second derivative) is obtained.
An advantage of this technique is, that a correction can be applied without the
intermediate step of wavefront reconstruction. Some correction devices, especially
bimorph mirrors, can locally deform into near-spherical shape. If the sensor
subapertures and the corrector actuators are aligned, a very efficient process for
wavefront sensing is the result.
A.5 Bimorph mirror
A deformable bimorph mirror consists of a glass or metal frontplate bonded to a
piezoelectric ceramic. The interface glued between the frontplate and the ceramic
contains a conducting electrode. The back of the ceramic is covered with a
number (matching the geometry of the detector) of electrodes. The front surface
is polished to form the reflective surface of the deformable mirror. If a voltage
is applied between the front electrode and one of the electrodes at the back, the
ceramic changes in size and a curvature is induced on the surface.
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A.6 Segmented mirror
Segmented mirrors are made of a number of small mirror elements with piston or
tilt capability. Piston mirrors can only perform up-and-down movement, chang-
ing the phase of a reflelcted wavefront. In piston-tilt mirrors each element can
additionally perform a tilt movement in the x and y direction.
A.7 The liquid crystal spatial light modulator
A liquid crystal spatial light modulator (SLM) is a compact low-cost alternative
to deformable mirrors [74]. The refractive index of the material and therefore
the optical pathlength is changed. To act as a piston-only segmented deformable
mirror the SLM has to be used with polarized light. SLMs can be used in trans-
mission, which can be useful in some applications.
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